Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and Disease Models, Animal

vancomycin has been researched along with Disease Models, Animal in 414 studies

Research

Studies (414)

TimeframeStudies, this research(%)All Research%
pre-199027 (6.52)18.7374
1990's37 (8.94)18.2507
2000's111 (26.81)29.6817
2010's186 (44.93)24.3611
2020's53 (12.80)2.80

Authors

AuthorsStudies
Bye, R; Janso, JE; Maiese, WM; Martínez, E; Mata, R; Morales, G; Singh, MP; Timmermann, B1
Bürli, RW; Chen, A; Duan, JX; Ge, Y; Gross, M; Hu, W; Iwamoto, M; Jiang, V; Johnson, KW; Jones, P; Kaizerman, JA; Moser, HE; Stanton, T; Touami, S; Truong, K1
Cottagnoud, M; Cottagnoud, P; Schaffner, T; Stucki, A; Winkelmann, V1
Fein, M; Kong, L; Oluola, O; Weisman, LE1
Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T1
Calhoun, JH; Schmitt-Hoffmann, A; Shapiro, S; Thomas, JK; Yin, LY1
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kihara, R; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Tsukamoto, K; Yamamoto, Y; Yanagihara, K1
Laohavaleeson, S; Nicolau, DP; Tessier, PR1
Almela, M; Amat, E; Armero, Y; de la Mària, CG; del Río, A; Gatell, JM; Jiménez de Anta, MT; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Soy, D1
Abbanat, D; Bush, K; Fernandez, J; Goldschmidt, R; Hilliard, JJ; Macielag, MJ; Melton, J1
Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P1
Bassett, J; Goldstein, BP; Heine, HS; Miller, L; Purcell, BK1
Crandon, JL; Kuti, JL; Nicolau, DP1
Bommineni, GR; Cummings, JE; Gu, C; Kapilashrami, K; Knudson, SE; Lu, Y; Slayden, RA; Tonge, PJ; Walker, SG1
Brewer, J; Dean, K; Ding, J; Dzink-Fox, J; Gamber, G; Jain, A; Kerrigan, R; Krastel, P; LaMarche, MJ; Lee, K; Leeds, JA; Lombardo, F; McKenney, D; Neckermann, G; Osborne, C; Palestrant, D; Patane, MA; Rann, EM; Robinson, Z; Schmitt, E; Stams, T; Tiamfook, S; Whitehead, L; Yu, D1
Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO1
Deng, Y; Duan, Y; Huang, Y; Kang, D; Li, Y; Liu, X; Qiu, L; Shen, B; Su, M; Wen, Z1
Dai, M; Kyei-Baffour, K; Mohammad, H; Seleem, MN1
Etayash, H; Hancock, REW; Kumar, P; Pletzer, D; Straus, SK1
Abouelhassan, Y; Chojnacki, M; Ding, Y; Dunman, PM; Fuse, MA; Huang, G; Huigens, RW; Jin, S; Kallifidas, D; Kundra, S; Lemos, JA; Liu, K; Luesch, H; Rohde, KH; Yang, H; Zhang, P1
Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH1
Chen, LP; Guo, Y; Huang, QR; Shi, HH; Wang, CC; Wang, YM; Xue, CH; Zhang, TT1
Fan, X; Hu, Y; Li, H; Liao, R; Wang, H; Wang, W; Xie, J; Zeng, M1
Connell, S; Fukuda, S; Imada, T; Kawashima, M; Nakamura, S; Tsubota, K; Yamamoto, H1
Chen, L; Tong, K; Wang, H; Wei, J; Wen, Y; Zhou, S1
Cheng, L; Cui, C; Hong, H; Hong, Y; Li, CS; Niu, GY; Qiao, CM; Quan, W; Shen, YQ; Shi, Y; Wu, J; Wu, YB; Zhao, LP; Zhao, WJ; Zhou, Y1
Delaney, LJ; Fitzgerald, K; Harwood, M; Hickok, NJ; Isguven, S; Schaer, TP1
Meng, L; Yang, H; Yang, J1
Ariki, S; Chalalai, T; Dewayani, A; Fujitsuka, N; Fukuda, C; Hidano, S; Ishizawa, S; Ito, K; Kamiyama, N; Kobayashi, T; Kubota, K; Kudo, Y; Minata, M; Mizukami, K; Mogami, S; Murakami, K; Nishiyama, M; Ozaka, S; Ozaki, T; Sachi, N; Soga, Y; Sonoda, A1
Awoniyi, M; Bajaj, JS; Bang, C; Farmer, M; Francis, HL; Franke, A; Hov, JR; Hylemon, PB; Kummen, M; Lai, Y; Lu, K; Meadows, V; Montgomery, S; Ngo, B; Popov, YV; Sartor, RB; Schramm, C; Tam, J; Thingholm, L; Ting, J; Viswanathan, A; Wang, J; Zhou, H1
Bentley, KLM; Cherian, P; Ebetino, FH; Galloway, CA; Hofstee, MI; Liu, Y; Moriarty, TF; Neighbors, J; Rainbolt, J; Ren, Y; Schwarz, EM; Sun, S; Xie, C; Xue, T1
Budi, ND; Godfrey, JJ; Rose, WE; Safdar, N; Shukla, SK1
Bianchimano, P; Britton, GJ; Clemente, JC; Cox, LM; Faith, JJ; Iwanowski, K; Liu, S; Smith, EM; Tankou, SK; Wallach, DS; Weiner, HL1
Lin, X; Wan, J; Wang, L; Xiang, Q; Yan, X; Zhang, W; Zhao, W; Zheng, H1
Fujisaka, S; Furusawa, Y; Ichimura-Shimizu, M; Igarashi, N; Kani, K; Kasai, K; Nagai, Y; Tada, Y; Takano, S; Takatsu, K; Tobe, K; Tsuneyama, K; Usui-Kawanishi, F; Watanabe, S; Yanagibashi, T1
Hasan, N; Yang, H1
Jiang, T; Liu, Y; Song, W; Su, X; Wang, B; Wang, R; Xu, Y; Yuan, D; Zhao, C1
Bi, Z; Chen, C; Hamilton, MJ; Khoruts, A; Roy, S; Sadowsky, MJ; Su, R; Zhang, L; Zhou, Y1
Cherian, P; de Mesy Bentley, KL; Ebetino, FH; Liu, Y; Masters, E; McKenna, CE; Neighbors, J; Rainbolt, J; Ren, Y; Schwarz, EM; Shu, Y; Sun, S; Weeks, J; Xie, C; Xue, T1
Awad, MM; Cunningham, BA; Day, SL; Drinkwater, N; Hutton, ML; Lyras, D; McGowan, S; Singleton, J; Srikhanta, YN1
Han, H; Li, S; Song, Z; Wang, H; Wu, Y1
Alt, V; Brunotte, M; Domann, E; Heiss, C; Lips, KS; Mohammed, W; Rupp, M; Sommer, U; Stötzel, S; Thormann, U1
Daibata, M; Fukuda, K; Fukushima, A; Ishida, W; Kishimoto, T; Matsuzaki, S; Nakajima, I; Suzuki, T; Todokoro, D; Uchiyama, J1
Flannigan, KL; Greenway, SC; Hirota, SA; Lewis, IA; Mohamud, A; Rahim, H; Taylor, MR1
McCune, BT; Pfeiffer, JK; Robinson, CM; Woods Acevedo, MA1
Bülbül, M; Çabuk, F; Çabuk, H; Güler, Y; Kiliç, E; Kuyucu, E1
Bostrom, MPG; Boyle, KK; Osagie, L; Sosa, B; Turajane, K; Yang, X1
Baruch, A; Cai, H; Deng, R; Guo, F; Hazenbos, W; Kamath, AV; Lewin-Koh, N; Xu, D; Yang, M; Zhou, C1
Brancaglion, GA; Corsetti, PP; Cristina de Melo Santos, N; de Almeida, LA; Novaes, RD; Pereira, JA; Rosa, CP; Silva, EN; Tagliati, CA1
Beard, MC; Cobb, LH; McCabe, EM; Olivier, AK; Park, J; Priddy, LB; Rourke, AS; Seo, KS; Swanson, EA1
El Khoury, G; Khazzaka, A; Rizkallah, M; Roukoz, S; Saghbini, E; Saliba, I1
Chen, Y; Cui, Z; Huang, L; Qi, Y; Sun, HT; Wang, FZ; Xu, CP; Yang, QP; Yang, YJ; Yu, B1
Chen, JY; Huang, HN; Pan, CY; Su, BC; Wu, HY1
Kiick, KL; Sullivan, MO; Thapa, RK1
Elliott, L; Grant, AL; Hazratwala, K; Letson, HL; McEwen, P; Morris, JL; Wilkinson, M1
Bernthal, NM; Hegde, V; Loftin, AH; Niska, J; Segura, T; Stavrakis, AI; Weixian, X; Zhu, S1
Brescini, L; Cirioni, O; Giacometti, A; Lazzarini, R; Lucarini, G; Morroni, G; Offidani, A; Orlando, F; Provinciali, M; Simonetti, O; Zizzi, A1
Baba, T; Enami, J; Hiramatsu, K; Ohsawa, H1
Antonangeli, F; D'Alessandro, G; Lauro, C; Limatola, C; Marrocco, F; Porzia, A; Santoni, A1
Landell, MF; Loges, LA; Macedo, AJ; Paulino, GVB; Silva, DB1
Boyce, TG; Karau, MJ; Kohrs, NJ; Larson, AN; Mandrekar, JN; Milbrandt, TA; Patel, R; Puleo, DA; van Wijnen, AJ; Zhang, C1
Aoki, K; Chono, K; Ishii, Y; Konishi, H; Tateda, K; Yamaguchi, T1
Choi, SM; Jang, HC; Jung, SI; Kang, G; Kim, HK; Lee, DG; Lee, S; Park, KH; Park, WB; Rhee, SJ1
Avedissian, SN; Downes, KJ; Liu, J; Moorthy, GS; Pais, GM; Rhodes, NJ; Scheetz, MH; Zepcan, S1
Chang, EB; Chen, EB; Demsas, F; Eskandari, M; Ho, KJ; Jiang, Q; Layden, BT; Nooromid, M; Priyadarshini, M; Shapiro, K; Xiong, L1
Bostrom, M; Carli, A; Fischetti, V; Niu, Y; Sosa, BR; Staats, K; Suhardi, V; Turajane, K; Yang, X1
Fitridge, R; Kifelew, LG; Mitchell, JG; Morales, S; Speck, P; Vaughan, L; Warner, MS; Woodman, R1
Cai, D; Diao, L; Hu, Y; Shen, A; Tao, J; Wang, L; Yang, Y; Zhang, Y1
Abdel, MP; Albano, M; Berry, DJ; Karau, MJ; Mandrekar, JN; Oravec, CP; Osmon, DR; Patel, R; Rivera, CG; Schmidt-Malan, SM1
AbdelKhalek, A; Seleem, MN1
Bauduin, M; Beury, D; Dessein, R; Faure, K; Faveeuw, C; Figeac, M; Gosset, P; Grandjean, T; Guery, B; Kipnis, E; Le Guern, R1
Amjad, T; Becker, S; Behera, GK; Chen, J; Cho, JM; Cunningham, SA; Dunny, G; Greenwood-Quaintance, KE; Jeraldo, PR; Jones-Hall, Y; Kashyap, PC; Mendes-Soares, H; Patel, R; Pu, M1
Liu, HM; Song, C; Wan, S; Wang, B; Wei, P; Yang, S; Yao, Y; Zhu, GM1
Cait, A; Cait, J; Canals Hernaez, D; McNagny, KM; Messing, M1
Bachali, P; Cabana Puig, X; Cecere, TE; Edwards, MR; Grammer, AC; Grieco, J; Lipsky, PE; Luo, XM; Mao, J; Mu, Q; Prakash, M; Puglisi, C; Reilly, CM; Swartwout, BK; Zhu, J1
Bernthal, NM; Bispo, M; Blumstein, G; Burke, Z; Czupryna, J; Francis, KP; Hamad, C; Hegde, V; Hoang, J; López-Álvarez, M; Miller, LS; Park, HY; Romero Pastrana, F; Sheppard, W; Smith, R; Sprague, M; van Dijl, JM; van Oosten, M; Zoller, SD1
Algarate, S; Arias, M; Comas, L; Domingo, MP; Esteban, P; Galvez, EM; Lopez, C; Millán-Lou, MI; Pardo, J; Redrado, S; Rezusta, A; Seral, C1
Amiri, N; Bazzaz, BSF; Beheshti, M; Foroghinia, N; Hashemi, M; Jirofti, N; Kalalinia, F; Movaffagh, J; Pishavar, E; Shahroodi, A; Tabassi, SAS; Taherzadeh, Z1
Burrello, C; Caprioli, F; Facciotti, F; Giuffrè, MR; Lattanzi, G; Pujolassos, M; Strati, F; Troisi, J1
Aardema, ND; Benninghoff, AD; Hintze, KJ; Rodriguez, DM; Van Wettere, AJ1
Azhari, H; Chen, XY; Mat Rani, NNI; Mohd Amin, MCI; Mustafa Hussein, Z; Mustapa, F; Sekar, M1
Alghazali, K; Anderson, DE; Beenken, KE; Biris, AS; Bourdo, SE; Campbell, MJ; Griffin, C; Hecht, S; Jackson, B; King, W; Meeker, DG; Ramirez, AM; Rifkin, R; Smeltzer, MS; Walker, CM1
Asmus, F; Bittinger, K; Brackin, R; Couture, S; Davis, R; Fisher, A; Friedman, ES; Giuvelis, D; Harrington, K; King, T; Lee, JJ; Liff, J; Mattei, LM; May, M; Mutina, E; Payne, E; Richard, P; Rostama, B; Sannajust, S; Stevenson, GW1
Faller, WJ; Garcia, TM; Koelink, PJ; Koster, J; Meisner, S; Muncan, V; Renes, IB; Silva, J; Smit, WL; van Elburg, RM; van Roest, M; Vermeulen, JLM; Wildenberg, ME1
Cai, GQ; Gui, R; Huang, R; Li, J; Li, XS; Liu, HT; Nie, XM; Shang, XL; Zhou, JD1
Shin, JH; Warren, CA1
Devocelle, M; Fitzgerald-Hughes, D; Forde, É; Hogan, S; Humphreys, H; O'Gara, JP; O'Neill, E; Zapotoczna, M1
Drew, A; Frederiksen, H; Kubiak, EN; Loc-Carrillo, C; Working, ZM1
Ishii, M; Matsumoto, Y; Moriya, K; Okazaki, M; Sato, T; Sekimizu, K; Tabuchi, F; Tatsuno, K2
Akers, KS; Shiels, SM; Tennent, DJ; Wenke, JC1
Álvarez-Lobos, M; Díaz-González, F; Paredes-Sabja, D; Pizarro-Guajardo, M1
Chen, AF; Dong, XH; Peng, C; Tao, X; Tao, YL; Xie, HH; Zhang, C; Zhang, YY1
Dong, Y; Li, J; Li, P; Yu, J1
Han, QZ; Li, XX; Ma, Y; Qian, XF; Shi, JF; Xu, J; Zhang, XF; Zhang, Y; Zhao, LN1
Hovis, JP; Joshi, M; Manson, TT; Marinos, D; Montalvo, R; OʼToole, RV; Shirtliff, ME1
Ajami, NJ; Chesnel, L; Cope, JL; Petrosino, JF; Wong, MC1
Bittinger, K; Bushman, FD; Facciabene, A; Ganetsky, A; Gill, S; Guedan, S; June, CH; Morgan, MA; Pierini, S; Rafail, S; Tanes, C; Tanyi, JL; Uribe-Herranz, M1
Ajami, NJ; Auchtung, TA; Banerjee, S; Berger, FG; Carson, JA; Chakraborty, P; Chanda, A; Chatzistamou, I; Chumanevich, A; Debnath, I; Depaep, S; Fayad, R; Gummadidala, PM; Kaur, K; O'Brien, JL; Omebeyinje, MH; Petrosino, JF; Saxena, A; Sougiannis, AJ1
Awais, R; Beenken, KE; Boles, LR; Haggard, WO; Jessica, AJ; Smeltzer, MS1
Shiels, SM; Tennent, DJ; Wenke, JC1
Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Sun, H; Wang, C; Wen, S; Yang, S; Zhu, Y1
Chen, Y; Huang, C; Sun, R; Tian, Z; Wang, J; Wei, H; Zheng, X; Zhou, R1
Channabasappa, S; Chikkamadaiah, R; Durgaiah, M; Kumar, S; Ramesh, K; Sreekanthan, A; Sriram, B1
Caroom, C; Fry, M; Hamood, A; Jenkins, M; Moore, D; Mudaliar, N; Murphree, J; Ratheal, I; Tullar, J; Winkler, C1
Du, H; Gan, Z; Guo, B; Tang, X; Wang, Z; Yu, X1
Abdelraouf, K; Kidd, JM; Nicolau, DP1
Fukui, H; Inoue, Y; Miwa, H; Oshima, T; Ran, Y; Tomita, T; Watari, J; Xu, X1
Wang, Y; Wu, J; Xia, Y; Xu, S; Zhang, H; Zhang, Y; Zhou, P1
Huang, X; Shen, L; Shou, D; Wang, P; Wang, X; Xi, W; Yu, Z; Zhang, Y1
Chen, Z; Cui, R; Feng, H; Yang, X; Ying, S; Zhan, X; Zhang, C; Zhong, L1
Cassisa, V; Chenouard, R; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Sanderink, D1
Akizawa, K; Fukumoto, T; Kaku, N; Kimura, H; Konno, S; Morinaga, Y; Nagaoka, K; Suzuki, M; Yamashita, Y; Yanagihara, K1
Fusco, DN; He, Y; Liu, X; Papanicolaou, GA; White, JR; Xiao, K1
King, LB; Marquart, ME; Moore, QC; Norcross, EW; Sanders, ME; Taylor, S; Thompson, H; Tullos, N1
Bělohlávek, J; Bouček, T; Fichtl, J; Hodková, G; Huptych, M; Kittnar, O; Linhart, A; Mlček, M; Mrázek, V; Springer, D; Zima, T1
Afasizheva, A; Badiou, C; Chambers, HF; Diep, BA; Kajikawa, O; Le, HN; Lina, G; Matute-Bello, G; Sellman, B; Tkaczyk, C1
Cavanagh, JP; Christophersen, L; Flaegstad, T; Fredheim, EA; Granslo, HN; Jensen, PØ; Klingenberg, C; Moser, C; Thomsen, K; Van Gennip, M1
Erdurmus, M; Hakyemez, IN; Kucukbayrak, A; Mengeloglu, FZ; Ozyalvacli, G; Simavli, H; Tas, T1
Beamer, G; Bowlin, T; Butler, M; Steele, J; Tzipori, S; Zhang, Q1
Barajas, G; Malczynski, M; McLaughlin, M; Qi, C; Radetski, J; Scheetz, MH; Zembower, T1
Gulmen, S; Kaya, S; Kurtoglu, T; Meteoglu, I; Okutan, H1
Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D1
Murray, CK; Penn-Barwell, JG; Wenke, JC1
Akdeniz, H; Bayram, R; Bucak, Ö; Bucak, YY; Erdurmuş, M; Küçükbayrak, A; Mengeloğlu, FZ; Özyalvaçlı, G; Taş, T1
Cheung, L; Crane, LM; de Goffau, MC; Francis, KP; Gazendam, JA; Harmsen, HJ; Lim, E; Ntziachristos, V; Ohlsen, K; Olive, M; Schäfer, T; Tsompanidou, E; van Dam, GM; van Dijl, JM; van Oosten, M1
Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A1
Chang, Z; Chen, Q; Hou, T; Li, Z; Luo, F; Wu, X; Xie, Z; Xing, J; Xu, J; Yu, B1
Guehring, T; Helbig, L; Lorenz, H; Moghaddam, A; Putz, C; Schmidmaier, G; Simank, HG; Suda, AJ; Wölfl, C1
Bayer, A; French, SW; Gebremariam, T; Ibrahim, AS; Lee, H; Luo, G; Spellberg, B; Xiong, YQ1
Bellini, D; Ferrari, A; Fini, M; Giavaresi, G; Meani, E; Meraner, J; Romanò, CL; Sacchetta, AC; Sambri, A; Sambri, V; Sartori, M; Vocale, C1
Fraenkel, P; Geiger, BM; Gras-Miralles, B; Karagiannis, AK; Kokkotou, E; Zhen, A; Ziogas, DC1
Almirante, B; Basas, J; Del Pozo, JL; Fernández-Hidalgo, N; Gavaldà, J; Martín, MT; Meije, Y; Pahissa, A; Shan, A1
Cui, X; Ding, H; Gu, YF; Huang, WH; Jia, WT; Rahaman, MN; Wang, Y; Zhang, CQ; Zhao, CJ1
Blasi, F; Chastre, J; Masterton, RG; Rello, J; Torres, A; Welte, T1
Altare, F; Asehnoune, K; Broquet, A; Caillon, J; Davieau, M; Jacqueline, C; Potel, G; Roquilly, A1
Inoue, Y; Kishi, K; Ochiai, H; Ohsugi, I; Sakamoto, Y; Yoshimura, Y1
Nakanishi, Y; Ohteki, T; Sato, T1
Cabellos, C; Force, E; Garrigós, C; Pachón-Ibañez, ME; Taberner, F1
Ayers, DC; Filion, TM; Lange, J; Li, X; Skelly, JD; Song, J1
Crémieux, AC; Gatin, L; Ghout, I; Laurent, F; Saleh-Mghir, A; Tasse, J1
Abdala, E; Costa, SF; D'Albuquerque, LA; Galvao, FH; Levin, AS; Lopes, CG; van der Heijden, IM; van der Heijden, KM1
Dagnæs-Hansen, F; Fuursted, K; Jørgensen, NP; Meyer, R; Meyer, RL; Petersen, E1
Hamaguchi, T; Horibe, S; Inoue, J; Kawauchi, S; Miki, I; Mizuno, S; Nakamura, T; Nishikawa, C; Tanahashi, T; Yasui, H1
Datta, V; Hamilton, M; Hilliard, JJ; Jones-Nelson, O; Nguyen, V; O'Day, T; Prokai, L; Sadowska, A; Sellman, BR; Stover, CK; Suzich, J; Szarka, S; Tkaczyk, C; Weiss, WJ1
Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF1
Baluya, D; Boyne, MT; Brown, D; Drusano, GL; Fikes, S; Huntley, C; Kurhanewicz, S; Liu, W; Louie, A; Patel, V; Robbins, N; Rodriquez, J1
Awad, HA; Inzana, JA; Kates, SL; Schwarz, EM1
Mandrekar, JN; Patel, R; Schmidt-Malan, SM; Steckelberg, JM; Vergidis, P1
Payne, L; Sattar, A; Thommes, P; Vickers, RJ; Warn, P1
Alpfidan, I; Demir, LS; Goktas, S; Kurtoglu, MG; Omeroglu, E; Ozcimen, M; Ozcımen, S; Saglam, F; Sakarya, R; Sakarya, Y; Yener, HI1
Bozoglan, O; Celik, A; Ciralik, H; Elveren, S; Eroglu, E; Gul, M; Mese, B; Yasim, A; Yildirimdemir, HI1
Liu, W; Lv, Z; Peng, G; Su, J; Xu, H1
Campagnari, AA; Cole, R; Ehrensberger, MT; Hansen, L; Luke-Marshall, NR; Nodzo, S; Tobias, M; Wild, L1
Chakraborty, SP; Haldar, J; Konai, MM; Mani, B; Manjunath, GB; Paramanandham, K; Prakash, RG; Ranjan, SB; Ravikumar, R; Roy, S; Yarlagadda, V1
Buffie, CG; Carter, RA; Gobourne, A; Leiner, I; Lewis, BB; Ling, L; Miller, LC; Pamer, EG; Toussaint, NC1
Gui, QF; Lu, HF; Xu, ZR; Yang, YH; Zhang, CX1
Angsantikul, P; Carpenter, C; Chen, TC; Chien, S; Dehaini, D; Fang, RH; Gao, W; Hofman, FM; Hu, CM; Kroll, AV; Luk, BT; Nguyen, P; Patel, SH; Qu, V; Ramesh, M; Shi, W; Thamphiwatana, S; Wang, KC; Wen, CH; Zhang, K; Zhang, L; Zhu, J1
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S1
Haldar, J; Paramanandham, K; Samaddar, S; Shome, BR; Yarlagadda, V1
Cheng, J; Hu, L; Li, J; Liu, Y; Lv, N; Yang, H; Ye, Y1
Aizic, A; Barnea, Y; Carmeli, Y; Dunne, MW; Lerner, A; Navon-Venezia, S; Puttagunta, S; Rachi, E1
Awad, HA; Inzana, JA; Kates, SL; Schwarz, EM; Trombetta, RP1
Hu, Z; Li, LL; Ma, HL; Qi, GB; Wang, H; Yu, F; Zhang, D1
Albayati, ZA; Breen, PJ; Crooks, PA; Karau, MJ; Merten, KE; Morris, AJ; Patel, R; Pierce, WM; Schmidt-Malan, SM; Smeltzer, MS; Steckelberg, JM; Sunkara, M; Taylor, KG1
Docobo-Pérez, F; Felton, TW; Goodwin, J; Hope, WW; Jacqz-Aigrain, E; Johnson, A; Livermore, J; McEntee, L; Ramos-Martín, V; Sharland, M; Turner, MA; Whalley, S; Zhao, W1
Beenken, KE; Courtney, HS; Haggard, WO; Jennings, JA; Parker, AC; Smeltzer, MS; Smith, JK1
Ahn, R; Campagnari, AA; Ehrensberger, MT; Hansen, L; Howard, C; Luke-Marshall, NR; Nodzo, SR; Tobias, M; Wild, L1
Boudjemaa, R; Boutoille, D; Breteche, A; Caillon, J; Fontaine-Aupart, MP; Jacqueline, C; Le Mabecque, V; Michelet, C; Potel, G; Revest, M; Steenkeste, K; Tattevin, P1
Heath, PT; Hill, LF; Lestner, JM; Sharland, M1
Arnold, PM; Ghogawala, Z; Tamerler, C1
Bellary, SS; Hsu, EL; Hsu, WK; Kannan, AS; Mendoza, MC; Mitchell, SM; Park, C; Singh, G; Sonn, KA; Stock, SR; Yun, C1
Dagnæs-Hansen, F; Fuursted, K; Jørgensen, NP; Meyer, RL; Petersen, E; Skovdal, SM1
Isobe, K; Ito, S; Tanaka, Y1
Abu-Kishk, I; Bahat, H; Berkovitch, M; Dagan, Z; Goldman, M; Klin, B; Kozer, E; Sabler, IM; Sandbank, J; Stav, K; Zisman, A1
Chan, EC; Chan, SC; Cheng, RC; Lai, CF; Lin, SS; Liu, SJ; Ueng, SW; Wang, IC; Yang, CY; Yuan, LJ1
Cahill, MP; Herrera, A; Merriman, JA; Salgado-Pabón, W; Schlievert, PM; Stach, CS; Vu, BG1
Akers, KS; Niece, KL; Sanchez, CJ; Shiels, SM; Stinner, DJ; Tennent, DJ; Wenke, JC1
Schuch, R; Wittekind, M1
Abdelhady, W; Bayer, AS; Tang, C'; Xiong, YQ1
Ashbaugh, AG; Bernthal, NM; Hegde, V; Loftin, AH; Miller, LS; Niska, JA; Segura, T; Stavrakis, AI; Zhu, S1
Arakawa, T; Fujiwara, Y; Gi, M; Nagami, Y; Sawada, A; Shiba, M; Tanaka, F; Tanigawa, T; Tominaga, K; Wanibuchi, H; Watanabe, T; Yamagami, H1
Bongio, M; Bottagisio, M; De Vecchi, E; Drago, L; Ferrario, M; Lovati, AB; Perego, S; Romanò, CL; Sansoni, V1
Black, T; Corbett, D; Flattery, A; Hernandez, LD; Sattar, A; Therien, AG; Thommes, P; Warn, P; Zhang, Z1
Greenwood-Quaintance, KE; Mandrekar, J; Park, KH; Patel, R1
Aladegbami, BG; Barron, LK; Erwin, CR; Gayer, CP; Golden, JM; Guo, J; Roberts, A; Warner, BW1
Akkapeddi, P; Haldar, J; Manjunath, GB; Paramanandham, K; Ravikumar, R; Sarkar, P; Shome, BR; Yarlagadda, V1
Aguiar-Alves, F; Badiou, C; Basuino, L; Chambers, HF; Diep, BA; Dip, EC; Duong, AH; Kajikawa, O; Le, HN; Le, VT; Lina, G; Mai, TT; Marbach, H; Matute-Bello, G; Pinheiro, MG; Rasigade, JP; Sarda, MN; Sellman, BR; Tkaczyk, C; Wang, X1
Aguilar, JL; Dutta, K; Fries, BC; Nosanchuk, JD; Pechuan, X; Varshney, AK1
Chen, X; D'Auria, G; Duan, Y; Džunková, M; Huang, J; Kelly, CP; Moya, A; Xu, H1
Al-Dhabi, NA; Chen, S; Deng, S; Duraipandiyan, V; Fang, J; Hao, Y; Li, S; Liu, G; Xu, B1
Cai, C; Jin, S; Ran, Z; Shen, J; Song, D; Zhao, D; Zheng, Q1
Hattori, N; Hirano, K; Iwanaga, N; Izumikawa, K; Kajihara, T; Kohno, N; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Nakamura, S; Oshima, K; Yanagihara, K1
Domínguez-Herrera, J; Labrador-Herrera, G; López-Rojas, R; Pachón, J; Smani, Y1
Chun, DS; Cook, RW; Edelstein, AI; Hsu, EL; Hsu, WK; Kannan, A; Mitchell, SM; Monroe, E; Stulberg, SD; Weiner, JA1
Bernthal, NM; Dworsky, E; Francis, KP; Hamad, CD; Hegde, V; Hu, Y; Johansen, D; Loftin, AH; Nelson, GE; Park, HY; Scaduto, A; Zoller, SD1
Choi, JY; Go, J; Kim, HJ; Lee, K; Lee, KM; Park, IH; Shin, JS; Yoon, SS1
Cheung, BM; Kwok, AK; Liu, F1
Barnea, Y; Carmeli, Y; Kuzmenko, B; Navon-Venezia, S1
Donta, I; Galani, L; Giamarellou, H; Iliopoulos, D; Karayiannakos, P; Pefanis, A; Sakka, V; Skiadas, I; Triantafyllidi, H1
Cheknis, A; Chen, X; Gerding, DN; Goldsmith, JD; Katchar, K; Kelly, CP; Nanthakumar, N1
Aybek, H; Baltalarli, A; Cevahir, N; Guler, A; Kaleli, I; Onem, G; Sacar, M; Sacar, S; Teke, Z; Turgut, H; Ucak, A1
Carias, LL; Hutton, R; Lakticová, V; Marshall, SH; Rice, LB; Rudin, S1
Adams, CS; Antoci, V; Ducheyne, P; Freeman, TA; Harrison, G; Hickok, NJ; Parvizi, J; Patal, P; Radin, S; Shapiro, IM1
Aabenhus, R; Andersen, LP; Ljungh, A; Permin, H; Stenram, U1
Bayer, AS; Cheung, AL; Memmi, G; Trotonda, MP; Xiong, YQ1
Bayer, AS; Fowler, VG; Kreiswirth, BN; Perdreau-Remington, F; Xiong, YQ; Yeaman, MR1
Kong, L; Placencia, FX; Weisman, LE1
Cabellos, C; Doménech, A; Force, E; Gudiol, F; Ribes, S; Taberner, F; Tubau, F; Viladrich, PF1
Kang, CI; Mook-Kanamori, BB; Patel, R; Rouse, MS; Steckelberg, JM; van de Beek, D1
Back, MR; Bandyk, DF; Heller, L; Johnson, BL; Keeling, WB; Myers, AR; Shames, ML; Stone, PA; Widen, R1
Brugman, S; Furuta, GT; Lindenbergh-Kortleve, D; Liu, KY; Nieuwenhuis, EE; Renshaw, SA; Samsom, JN; Willemsen, R1
Deresinski, S1
Eguchi, H; Kasama, T; Oguro, S; Shiota, H1
Blick, SK; Lyseng-Williamson, KA1
Chahales, P; Collin, M; Daniel, A; Euler, C; Fischetti, VA; Gorelick, KJ1
Bielewicz, M; Droździk, M; Grodzki, T; Kubisa, B; Pankowski, J; Pieróg, J; Safranow, K; Wójcik, J1
Builles, N; Couprie, J; Devouassoux, M; Fessi, H; Hachicha, W; Hartmann, D; Kodjikian, L; Timour, Q1
Hyon, SH; Ikeda, T; Marui, A; Morishima, M; Nakajima, N; Nomura, T; Sakata, R; Yanagi, S1
Charbonnel, N; Forestier, C; Henard, S; Lesens, O; Rabaud, C; Vidal, M1
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM1
Amador, G; Batard, E; Biek, D; Caillon, J; Ge, Y; Hamel, A; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G1
Agudelo, M; Rodriguez, CA; Salazar, BE; Vesga, O; Zuluaga, AF1
Ariza, J; Cabellos, C; Domínguez, MA; Fernández, R; Gudiol, F; Pachón-Ibáñez, ME; Ribes, S; Tubau, F2
Fey, PD; Olson, ME; Rupp, ME; Slater, SR1
Haggard, WO; Noel, SP; Stinner, DJ; Watson, JT; Wenke, JC1
Adali, F; Asan, A; Baltalarli, A; Cevahir, N; Kaleli, I; Onem, G; Sacar, M; Sacar, S; Susam, I; Teke, Z; Turgut, H; Yaylali, YT1
Amador, G; Asseray, N; Caillon, J; Jacqueline, C; Le Mabecque, V; Lefebvre, M; Miegeville, A; Potel, G1
Kim, JY; Kim, SY1
Li, H; Ma, Q; Pan, Z; Qi, Y; Shi, Z; Wang, X; Wang, Y; Xue, D1
Barman, TK; Bhatnagar, PK; Das, B; Kalia, V; Kumar, GR; Kumar, M; Mathur, T; Raj, VS; Singhal, S; Upadhyay, DJ1
Brescini, L; Cirioni, O; Dawgul, M; Ghiselli, R; Giacometti, A; Guerrieri, M; Kamysz, W; Myszka, H; Orlando, F; Silvestri, C1
Akinnusi, ME; El-Solh, AA; Gao, W; Hattemer, A1
Chen, K; Davis, B; Feng, H; Sun, X; Wang, H; Zhang, Y1
Callegan, MC; Griffin, G; Guess, S; Leonard, R; Wheatley, NR; Wiskur, BJ; Woods, DC1
Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Murillo, O; Tubau, F; Verdaguer, R1
Kalil, AC1
Agusti, C; de la Bellacasa, JP; Esperatti, M; Filella, X; Guerrero, L; Li Bassi, G; Liapikou, M; Luque, N; Marco, F; Martinez-Olondris, P; Quera, MA; Rigol, M; Soy, D; Torres, A1
Bayer, AS; Chen, L; Hady, WA; Kreiswirth, BN; Seidl, K; Xiong, YQ1
Pei, YL; Wang, JC; Yang, YH1
Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF1
Chakraborty, SP; Chattopadhyay, S; Das, S; Dash, SK; Pramanik, P; Roy, S; Tripathy, S1
Docobo-Pérez, F; Domínguez-Herrera, J; Lepe, JA; López-Rojas, R; Pachón, J; Pichardo, C; Ruiz-Valderas, R1
Dong, J; Fang, TL; Jiang, JL; Li, XL; Li, YF; Wang, YC; Zhou, J1
Bizzini, A; Entenza, JM; Giddey, M; Moreillon, P; Vouillamoz, J1
Brown, NC; Dvoskin, S; Wright, GE; Xu, WC; Yanachkov, IB; Yanachkova, M1
Crandon, JL; Hagihara, M; Keel, RA; Nicolau, DP; Tessier, PR1
Aybar, Y; Besirli, K; Engin, E; Karabulut, E; Mert, A; Mete, B; Ozaras, R; Ozturk, R; Salihoglu, T; Tabak, F; Tahan, G; Yilmaz, MH1
Bourcier, T; Jehl, F; Lefèvre, S; Marcellin, L; Prévost, G; Saleh, M; Subilia, A1
Ergun, H; Köseoglu-Eser, O; Mamuk, S; Melli, M; Saribas, Z1
Bosch, A; Calvo, M; Esperatti, M; Fernández-Barat, L; Ferrer, M; Gabarrús, A; Li Bassi, G; Luque, N; Martínez-Olondris, P; Rigol, M; Torres, A; Vila, J1
Docobo-Pérez, F; Domínguez-Herrera, J; Ibáñez-Martínez, J; Jiménez-Mejias, ME; López-Rojas, R; Pachón, J; Pichardo, C1
Douglas, G; Erickson, G; Grayson, JK; Large, TM1
Ballard, TE; Guerrant, RL; Hoffman, PS; Kennedy, A; Kolling, GL; Macdonald, TL; Olekhnovich, I; Riggins, M; van Opstal, E; Wang, X; Warren, CA; Warthan, M1
Acar, N; Bourcier, T; Gaucher, D; Jehl, F; Lefèvre, S; Marcellin, L; Prévost, G; Saleh, M; Subilia, A1
Cui, X; Huang, W; Jia, W; Wang, X; Zhang, C; Zhao, C1
Cheng, J; Hu, LF; Li, JB; Liu, YY; Mei, Q; Ye, Y; Zhu, YL1
Barr, S; Engiles, J; Hickok, NJ; Parvizi, J; Richardson, DW; Schaer, TP; Shapiro, IM; Stewart, S1
Chilton, CH; Crowther, GS; Fawley, WN; Freeman, J; Lehoux, D; Marquis, M; Moeck, G; Todhunter, SL; Wilcox, MH1
Fenical, W; Haste, NM; Hensler, ME; Jensen, PR; Loesgen, S; Nam, SJ; Nizet, V; Sakoulas, G; Sun, P; Thienphrapa, W; Tran, DN1
Buke, C; Calik, S; Sipahi, OR; Turhan, T; Yurtseven, T1
Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI1
Bracken, TC; Figler, RA; Guerrant, RL; Kolling, G; Li, Y; Linden, J; Rieger, J; Stevenson, RW; Warren, CA1
Ding, H; Jia, WT; Li, GY; Yin, JM; Zhang, CQ1
Arda, B; Bardak-Ozcem, S; Isikgoz-Tasbakan, M; Pullukcu, H; Sipahi, H; Sipahi, OR; Turhan, T; Ulusoy, S; Yamazhan, T1
Braga Neto, MB; Costa, LB; Guerrant, RL; Kolling, GL; Li, Y; Lima, AA; Oliveira, RA; Rodrigues, RS; Warren, CA; Zaja-Milatovic, S1
Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Miyazaki, Y; Murata, I; Sawai, T; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K1
Murray, BE; Nannini, EC; Pai, SR; Singh, KV1
Braggio, S; Di Modugno, E; Ferrari, L; Iavarone, L1
Chambers, HF; Moore, MR; Perdreau-Remington, F1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Pfister, M; Täuber, MG1
Chau, F; Denis, F; Fantin, B; Garry, L; Lefort, A; Massias, L; Pavie, J; Ploy, MC1
Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Riva, A; Saba, V; Scalise, G; Silvestri, C1
Balaban, N; Cirioni, O; D'Amato, G; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Gov, Y; Kamysz, W; Lukasiak, J; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G1
Arthur, M; Chau, F; Courvalin, P; Depardieu, F; Fantin, B; Lefort, A; Pouzet, C1
Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M1
Balaban, N; Cirioni, O; D'Amato, G; Del Prete, MS; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C1
Chambers, HF1
Brandt, B; Gosheger, G; Joist, A; Joosten, U; Liljenqvist, U; von Eiff, C1
Calhoun, JH; Lazzarini, L; Li, F; Stevens, CM; Yin, LY1
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA2
Bucher, RS; Hall, E; Johnson, MW; Reed, DM; Richards, JE; Zacks, DN1
Basuino, L; Chambers, HF; Madrigal, AG1
Hirai, Y; Kijima, K; Kurazono, M; Nagura, J; Shitara, E; Sugano, T; Takahata, S; Takayama, Y; Tanaka, Y; Yamada, K; Yonezawa, M1
Buke, C; Buke, M; Sipahi, OR; Suntur, BM; Yurtseven, T1
Arslan, MK; Candir, O; Ciris, M; Oktem, F; Ozguner, F; Uz, E; Yilmaz, HR1
Baines, SD; Freeman, J; Jabes, D; Wilcox, MH1
Lavoie, MC; Morency, H; Mota-Meira, M1
Cabellos, C; Domenech, A; Fernández Viladrich, P; Gudiol, F; Liñares, J; Ribes, S; Taberner, F; Tubau, F1
Cirioni, O; De Fusco, M; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Provinciali, M; Saba, V; Scalise, G; Silvestri, C1
Arda, B; Ozgiray, E; Sipahi, H; Sipahi, OR; Suntur, BM; Ulusoy, S; Yurtseven, T1
Catherall, EJ; Irwin, R; Mizen, L1
Olay, T; Rodríguez, A; Vicente, MV1
Adali, F; Baltalarli, A; Goksin, I; Onem, G; Ozcan, V; Sacar, M; Sacar, S; Turgut, H1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Gerber, P; Stucki, A1
Cabellos, C; Domenech, A; Gudiol, F; Liñares, J; Ribes, S; Taberner, F; Tubau, F; Viladrich, PF1
Agudelo, M; Rodriguez, CA; Salazar, BE; Vesga, O; Zapata, AX; Zuluaga, AF1
Alper, M; Cevher, E; Mülazimoğlu, L; Orhan, Z; Ozsoy, Y; Sensoy, D; Yildiz, A1
Benton, BM; Hegde, SS; Krause, KM; Obedencio, GP; Reyes, N; Shelton, J; Skinner, R1
Hanaki, H; Hatano, K; Sunakawa, K; Yokota, Y1
Chiodi, L; Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Vittoria, AD1
Tang, G; Wang, A; Wang, Z1
Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K1
Arai, Y; Fujita, M; Hirose, K; Inoue, S; Kamitani, T; Kaneda, K; Komeda, M; Marui, A; Mitsuyama, M; Nomura, T; Tabata, Y1
Alvarez, FG; Amorena, B; García-Alvarez, F; García-Alvarez, I; Grasa, JM; Laclériga, A; Monzón, M; Navarro-Zorraquino, M1
de Górgolas, M; Fernández Guerrero, ML1
Ariza, J; Cabellos, C; Doménech, A; Garcia, A; Gudiol, F; Murillo, O; Tubau, F1
Chan, EC; Lee, MS; Lin, SS; Liu, SJ; Ueng, SW1
Entenza, JM; Giddey, M; Moreillon, P; Vouillamoz, J1
Brookfield, KF; Chen, J; Chiappetta, G; Conaughty, JM; Eismont, FJ; Martinez, OV1
Anguita-Alonso, P; Balaban, N; Cirioni, O; Ghiselli, R; Giacometti, A; Orlando, F; Patel, R; Saba, V; Scalise, G; Sevo, M; Tuzova, M1
Arimoto, H; Hayashi, S; Lu, J; Yoshida, O1
Celik, S; Erdogan, S; Gorur, S; Hakverdi, S; Ocak, S1
Atahan, E; Ergun, Y; Eroglu, E; Gul, M1
Adah, F; Benghuzzi, H; England, B; Russell, G; Tucci, M1
Bostrom, M; Gardner, M; Griffith, M; Wanich, T; Zelken, J1
Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Vittoria, AD1
Adams, CS; Antoci, V; Hickok, NJ; Parvizi, J; Shapiro, IM1
Aktekin, CN; Altay, M; Erdemli, E; Karahuseyinoglu, S; Korkusuz, F; Ozturk, AM; Tabak, AY1
Aslan, C; Cetin, H; Ciris, M; Oktem, F; Olgar, S; Ozguner, F; Uz, E1
Batard, E; Caillon, J; Hamel, A; Jacqueline, C; Potel, G1
Hodoshima, N; Inui, K; Masuda, S1
Arai, Y; Bir, SC; Esaki, J; Hirose, K; Huang, Y; Ikeda, T; Komeda, M; Marui, A; Nomura, T; Sakaguchi, H; Tabata, Y1
Borsari, V; Fini, M; Gaibani, P; Giardino, R; Giavaresi, G; Sambri, V; Soffiatti, R1
Basaran, M; Kafali, E; Kalko, Y; Ogus, TN; Selimoglu, O; Ugurlucan, M; Us, MH1
Beckmann, J; Grifka, J; Kalteis, T; Kees, F; Lehn, N; Lerch, K; Schaumburger, J1
Brammer, DW; Brieland, JK; Courtney, CL; Gibson, GW; Hollembaek, JM; Huband, MD; Juneau, PL; Kreuser, SC; Riley, JM; Rosebury-Smith, WS; Sulavik, MC; Zhu, T1
De Kaspar, HM; Engelbert, M; Kampik, A; Mette, M; Ta, CN; Thiel, M1
Callegan, MC; Farrand, AJ; Novosad, BD; Robinson, ML; Wiskur, BJ1
Andes, DR; Craig, WA; LaPlante, KL; Leonard, SN; Rybak, MJ1
Cirioni, O; Ghiselli, R; Giacometti, A; Minardi, D; Mocchegiani, F; Muzzonigro, G; Orlando, F; Riva, A; Saba, V; Scalise, G; Silvestri, C; Skerlavaj, B; Tomasinsig, L; Zanetti, M1
Kaplan, EL1
Lowy, FD; Steigbigel, NH; Wexler, MA1
Sande, MA; Scheld, WM1
Bartlett, JG; Taylor, NS1
Murray, TW; Sande, MA; Strausbaugh, LJ1
Bartlett, JG; Chang, T; Dzink, J; Taylor, NS1
Boucher, BA; Croce, MA; Fabian, TC; McKindley, DS; Proctor, KG1
Cantor, JB; Guiboux, JP; Herkowitz, HN; Small, SD; Zervos, M1
Gagnon, RF; Richards, GK1
Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M1
Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R1
Johnson, CC; Levison, ME; Livornese, LL; Osborne, AJ; Pitsakis, PG; Whitman, MS; Zausner, A1
Caron, F; Gutmann, L; Humbert, G; Klare, I; Lemeland, JF1
Coudron, PE; Lavoie, SR; Markowitz, SM; Williams, DS; Wong, ES1
Kaiser, AB; Kernodle, DS1
Aguilar, HE; Drews, C; Gardner, S; Grossniklaus, H; Meredith, TA; Sawant, AD1
DeJesus, E; Johnson, CC; Levison, ME; Osborne, AJ; Pitsakis, PG; Whitman, MS1
Hatori, T; Matsumoto, T; Miyazaki, H; Takashima, K; Tateda, K; Yamaguchi, K1
Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ1
Buisson, M; Champliaud, D; Chavanet, P; Duong, M; Kazmierczak, A; Neuwirth, C; Pechinot, A; Portier, H1
Calhoun, JH; Mader, JT1
Benoit, MA; Bouillet, R; Delloye, C; Gillard, J; Mousset, B1
Goldstein, BP; Greenberg, K; Novick, R; Wei, J1
Kashani, A; Lee, G; Mondino, B; Palmer, J; Yoshizumi, MO1
De Vecchi, E; Drago, L; Fassina, MC; Gismondo, MR1
Ahmed, A; Jafri, H; Lutsar, I; McCoig, CC; McCracken, GH; Shelton, S; Trujillo, M; Wubbel, L1
Cottagnoud, M; Cottagnoud, P; Gerber, CM; Hänni, F; Neftel, K; Rodoni, D; Täuber, MG1
Bow, L; Bui, KQ; Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R1
Backo, M; Bayer, AS; Burkart, A; Chai, YL; Gaenger, E1
Cristofori, P; Di Modugno, E; Ladel, CH; Lanzoni, A; Marzola, P; Nicolato, E; Sbarbati, A1
Cottagnoud, M; Cottagnoud, P; Gerber, CM; Neftel, KA; Täuber, MG1
Espersen, F; Frimodt-Moller, N; Fuursted, K; Knudsen, JD; Raber, S1
Light, RW; Mulligan, ME; Nguyen, T; Sasse, SA; Teixeira, LR; Villarino, MA1
Greenstein, M; Kong, F; Petersen, PJ; Singh, MP; Weiss, WJ1
McVay, CS; Rolfe, RD1
Patel, R; Piper, KE; Ronningen, KL; Rouse, MS; Steckelberg, JM; Wilson, WR1
McCracken, GH1
Tateda, K; Yamaguchi, K1
Batts, DH; Buchanan, LV; Dailey, CF; Dileto-Fang, CL; Ford, CW; Gibson, JK; Oramas-Shirey, MP1
Cortés Sanchez, R; García Alberola, A; Gómez Gómez, J; López Fornas, F; Martínez García, F; Pérez Salmeron, J; Roldán Conesa, D; Ruíz Gómez, J; Valdés Chávarri, M1
Capdevila, JA; Fortea, J; Gavaldà, J; Gomis, X; López, P; Martin, MT; Pahissa, A1
Carbon, C; Courvalin, P; Fantin, B; Lafaurie, M; Lefort, A; Perichon, B1
Abe, T; Fukuoka, T; Inoue, H; Ohya, S1
Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C1
Andoh, A; Araki, Y; Bamba, T; Fujiyama, Y; Fukuda, M; Fukuoka, M; Kanauchi, O; Matsumoto, Y; Mitsuyama, K; Sata, M; Takagi, K; Toyonaga, A1
Cottagnoud, M; Cottagnoud, P; Gerber, CM; Täuber, MG1
Cabellos, C; Fernández, A; Gudiol, F; Liñares, J; Martínez-Lacasa, J; Martos, A; Tubau, F; Viladrich, PF1
Bisognano, C; Francois, P; Lew, DP; Schrenzel, J; Vaudaux, P1
Benum, P; Bergh, K; Persen, L; Witsø, E1
Akimitsu, N; Kaito, C; Sekimizu, K; Watanabe, H1
Hamilton-Miller, JM1
Appel, GB; Neu, HC1
Bartlett, JG1
Crow, J; Larson, HE; Price, AB1
Abrutyn, E; Lane, TW1
Browne, RA; Ebright, JR; Fekety, R; Rifkin, GD; Silva, J1
Bartlett, JG; Cisneros, RL; Onderdonk, AB1
Abrams, GD; Boyd, DI; Browne, RA; Fekety, R; Silva, J; Work, CO1
Johnson, ML; Sande, MA1
Durack, DT; Pelletier, LL; Petersdorf, RG1
Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C1
Rukhlina, AA1
Pizzo, PA; Walsh, TJ1
Callegan, MC; Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ2
Forster, RK1
Auckenthaler, R; Chuard, C; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA1
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM1
Cheng, AF; Donnan, S; French, GL; Ling, JM; Mo, P1
Auckenthaler, R; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA1
Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O1
Keating, MR; Rouse, MS; Steckelberg, JM; Wilson, WR1
Chang, TW; Dong, MY; Gorbach, SL1
Canawati, HN; Ginunas, VJ; Montgomerie, JZ; Sapico, FL1
Elmer, GW; McFarland, LV1
Grady, MS; Howard, MA; Park, TS; Scheld, WM1
Bayer, AS; Lam, K1
Li, ZJ; Liu, LX; Niu, HZ; Song, HY; Zhang, XY1
Jawetz, E1
Campos, ME; Rabinovich, S; Smith, IM1

Reviews

15 review(s) available for vancomycin and Disease Models, Animal

ArticleYear
Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.
    Pharmacotherapy, 2020, Volume: 40, Issue:5

    Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Disease Models, Animal; Humans; Vancomycin

2020
Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA).
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2021, Volume: 165

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Biological Availability; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Global Burden of Disease; Humans; Liposomes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prevalence; Staphylococcal Infections; Tissue Distribution; Treatment Outcome; Vancomycin

2021
Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens.
    Gut microbes, 2017, 09-03, Volume: 8, Issue:5

    Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Immunologic Factors; Mice; Recurrence; Vancomycin

2017
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26 Suppl 1

    Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2013
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20 Suppl 4

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Risk Factors; Vancomycin

2014
Vancomycin toxicity in neonates: a review of the evidence.
    Current opinion in infectious diseases, 2016, Volume: 29, Issue:3

    Topics: Acute Kidney Injury; Adult; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Gram-Positive Bacterial Infections; Hearing Loss; Humans; Infant, Newborn; Mice; Vancomycin

2016
Cell wall hydrolases and antibiotics: exploiting synergy to create efficacious new antimicrobial treatments.
    Current opinion in microbiology, 2016, Volume: 33

    Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Bacteriolysis; Cell Wall; Disease Models, Animal; Drug Synergism; Lysostaphin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Peptides, Cyclic; Peptidoglycan; Polymyxin B; Staphylococcal Infections; Vancomycin

2016
Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Oct-01, Volume: 49, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Randomized Controlled Trials as Topic; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin

2009
Vancomycin in infants and children: a review of pharmacology and indications for therapy and prophylaxis.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14 Suppl D

    Topics: Adolescent; Adult; Animals; Arteriovenous Shunt, Surgical; Cats; Child; Child, Preschool; Dental Plaque; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Kinetics; Male; Pregnancy; Rabbits; Staphylococcal Infections; Vancomycin

1984
Combination antibiotic therapy of bacterial endocarditis.
    Annals of internal medicine, 1980, Volume: 92, Issue:3

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Vancomycin

1980
Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31 Suppl 2

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Child; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Meningitis, Pneumococcal; Naphthyridines; Rabbits; Streptococcus pneumoniae; Vancomycin

2000
[Penicillin-resistant Streptococcus pneumoniae infections: current trends in epidemiology and antibiotic chemotherapy].
    Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Humans; Japan; Mice; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin

2000
Antimicrobial agents acting against anaerobes.
    The Journal of antimicrobial chemotherapy, 1975, Volume: 1, Issue:3

    Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamycin; Colistin; Disease Models, Animal; Erythromycin; Fusidic Acid; Humans; Lactams; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Nitroimidazoles; Polymyxins; Rifamycins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Vancomycin

1975
Antibiotic-associated colitis.
    Clinics in gastroenterology, 1979, Volume: 8, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1979
Chemotherapy of chlamydial infections.
    Advances in pharmacology, 1969, Volume: 7

    Topics: Animals; Anti-Bacterial Agents; Bacitracin; Bird Diseases; Birds; Chlamydia; Chlamydia Infections; Chloramphenicol; Conjunctivitis, Inclusion; Cycloserine; Disease Models, Animal; Erythromycin; Glycosides; Humans; Lymphogranuloma Venereum; Nystatin; Penicillins; Polymyxins; Psittacosis; Sulfonamides; Tetracycline; Trachoma; Vancomycin

1969

Trials

1 trial(s) available for vancomycin and Disease Models, Animal

ArticleYear
Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:7

    Topics: Aged; Aged, 80 and over; Animals; Carrier State; Colony Count, Microbial; Disease Models, Animal; Double-Blind Method; Electrophoresis, Agar Gel; Enterococcus; Escherichia coli; Feces; Humans; Lacticaseibacillus rhamnosus; Mice; Middle Aged; Phylogeny; Pilot Projects; Probiotics; Vancomycin; Vancomycin Resistance

2010

Other Studies

398 other study(ies) available for vancomycin and Disease Models, Animal

ArticleYear
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
    Journal of natural products, 2001, Volume: 64, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Asteraceae; Candida albicans; Disease Models, Animal; DNA; Drug Resistance, Microbial; Enterococcus faecium; Escherichia coli; Female; Magnetic Resonance Spectroscopy; Mexico; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Phenols; Plant Roots; Plants, Medicinal; Protein Biosynthesis; Proteins; RNA; Spectrophotometry, Ultraviolet; Staphylococcus aureus; Vancomycin

2001
DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids.
    Bioorganic & medicinal chemistry letters, 2004, May-03, Volume: 14, Issue:9

    Topics: Amino Acids, Aromatic; Animals; Anti-Bacterial Agents; Disease Models, Animal; DNA; Ligands; Lung Diseases; Mice; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae

2004
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacteriolysis; Ceftriaxone; Cell Wall; Cerebrospinal Fluid; Choline; Daptomycin; Disease Models, Animal; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Treatment Outcome; Tritium

2007
Lysostaphin in treatment of neonatal Staphylococcus aureus infection.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Animals; Animals, Suckling; Anti-Infective Agents, Local; Disease Models, Animal; Humans; Infant, Newborn; Lysostaphin; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome

2007
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
    Journal of medicinal chemistry, 2008, Apr-10, Volume: 51, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water

2008
Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Animals; Body Weight; Cephalosporins; Disease Models, Animal; Methicillin Resistance; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tibia

2008
Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Bronchopneumonia; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Humans; Lung; Male; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Specific Pathogen-Free Organisms; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance

2008
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus

2008
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Glycopeptides; Heart Valve Diseases; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2008
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Outcome; Vancomycin

2009
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin

2010
Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Administration, Inhalation; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Teicoplanin; Treatment Outcome

2010
Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia; Staphylococcal Infections; Vancomycin

2010
Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.
    Journal of medicinal chemistry, 2016, 06-09, Volume: 59, Issue:11

    Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Animals; Anti-Bacterial Agents; Burkholderia pseudomallei; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Francisella tularensis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Conformation; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes; Yersinia pestis

2016
Antibacterial and Solubility Optimization of Thiomuracin A.
    Journal of medicinal chemistry, 2016, 07-28, Volume: 59, Issue:14

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Peptides, Cyclic; Solubility; Structure-Activity Relationship; Thiazoles

2016
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
    European journal of medicinal chemistry, 2018, Jul-15, Volume: 155

    Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Skin Diseases, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Wound Infection

2018
Semisynthesis of Platensimycin Derivatives with Antibiotic Activities in Mice via Suzuki-Miyaura Cross-Coupling Reactions.
    Journal of medicinal chemistry, 2018, 12-27, Volume: 61, Issue:24

    Topics: Adamantane; Aminobenzoates; Anilides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Peritonitis; Staphylococcal Infections

2018
Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus.
    Bioorganic & medicinal chemistry, 2019, 05-01, Volume: 27, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nitriles; Skin Diseases; Staphylococcal Infections

2019
Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity.
    Journal of medicinal chemistry, 2020, 09-10, Volume: 63, Issue:17

    Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cell Proliferation; Cyclization; Disease Models, Animal; Disulfides; Drug Design; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Inflammation; Mice; Microbial Sensitivity Tests; Protein Aggregates; Protein Stability; Skin Diseases; Staphylococcal Infections

2020
A Modular Synthetic Route Involving
    Journal of medicinal chemistry, 2021, 06-10, Volume: 64, Issue:11

    Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Disease Models, Animal; Drug Design; Female; Halogenation; Humans; Iron; Iron Deficiencies; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phenazines; Staphylococcal Infections; Structure-Activity Relationship; Wound Healing

2021
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
    European journal of medicinal chemistry, 2021, Nov-15, Volume: 224

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship

2021
Docosahexaenoic Acid-Acylated Astaxanthin Esters Exhibit Superior Renal Protective Effect to Recombination of Astaxanthin with DHA via Alleviating Oxidative Stress Coupled with Apoptosis in Vancomycin-Treated Mice with Nephrotoxicity.
    Marine drugs, 2021, Aug-31, Volume: 19, Issue:9

    Topics: Acute Kidney Injury; Animals; Apoptosis; Aquatic Organisms; Disease Models, Animal; Docosahexaenoic Acids; Esters; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Protective Agents; Vancomycin

2021
Masquelet technique: Effects of vancomycin concentration on quality of the induced membrane.
    Injury, 2022, Volume: 53, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bone Cements; Disease Models, Animal; Polymethyl Methacrylate; Rabbits; Vancomycin

2022
Lactoferrin Ameliorates Dry Eye Disease Potentially through Enhancement of Short-Chain Fatty Acid Production by Gut Microbiota in Mice.
    International journal of molecular sciences, 2021, Nov-17, Volume: 22, Issue:22

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cytokines; Disease Models, Animal; DNA, Bacterial; Dry Eye Syndromes; Fatty Acids, Volatile; Female; Gastrointestinal Microbiome; Inflammation; Lactoferrin; Mice; Mice, Inbred C57BL; Protective Agents; Signal Transduction; Tears; Treatment Outcome; Vancomycin

2021
Intra-wound vancomycin powder for the eradication of periprosthetic joint infection after debridement and implant exchange: experimental study in a rat model.
    BMC microbiology, 2021, 12-07, Volume: 21, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Debridement; Disease Models, Animal; Knee Prosthesis; Methicillin-Resistant Staphylococcus aureus; Powders; Prosthesis-Related Infections; Rats; Rats, Wistar; Staphylococcal Infections; Treatment Outcome; Vancomycin

2021
Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2023, Volume: 18, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Dopamine; Inflammation; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Neuroprotection; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vancomycin

2023
In vitro investigations of Staphylococcus aureus biofilms in physiological fluids suggest that current antibiotic delivery systems may be limited.
    European cells & materials, 2022, 02-02, Volume: 43

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Gentamicins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2022
Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
    Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bifidobacterium breve; Clostridioides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Feces; Metronidazole; Mice; RNA, Ribosomal, 16S; Vancomycin

2022
Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    PloS one, 2022, Volume: 17, Issue:6

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Colitis; Colitis, Ulcerative; Disease Models, Animal; Drugs, Chinese Herbal; Dysbiosis; Herbal Medicine; Inflammation; Intestinal Mucosa; Japan; Mice; Mice, Inbred C57BL; Vancomycin

2022
Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC.
    Gut, 2023, Volume: 72, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Clostridiales; Disease Models, Animal; Escherichia coli; Inflammation; Liver Cirrhosis; Mice; RNA, Ribosomal, 16S; Vancomycin

2023
Efficacy of Bisphosphonate-Conjugated Sitafloxacin in a Murine Model of
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; Anti-Bacterial Agents; Diphosphonates; Disease Models, Animal; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Mice; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Vancomycin

2022
Efficacy of Omadacycline or Vancomycin Combined With Germinants for Preventing Clostridioides difficile Relapse in a Murine Model.
    The Journal of infectious diseases, 2023, 03-01, Volume: 227, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Mice; Recurrence; Vancomycin; Weight Loss

2023
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.
    Microbiome, 2022, 10-17, Volume: 10, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyrates; Clostridiales; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gastrointestinal Microbiome; Humans; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroinflammatory Diseases; Nuclear Receptor Subfamily 1, Group F, Member 3; Vancomycin

2022
Intestinal Microflora Altered by Vancomycin Exposure in Early Life Up-regulates Type 2 Innate Lymphocyte and Aggravates Airway Inflammation in Asthmatic Mice.
    Inflammation, 2023, Volume: 46, Issue:2

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Gastrointestinal Microbiome; Immunity, Innate; Inflammation; Lung; Lymphocytes; Mice; Mice, Inbred BALB C; Ovalbumin; Vancomycin

2023
Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.
    International journal of molecular sciences, 2023, Feb-17, Volume: 24, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Vancomycin

2023
Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models.
    PloS one, 2023, Volume: 18, Issue:5

    Topics: Animals; Capsules; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Mice; RNA, Ribosomal, 16S; Tumor Necrosis Factor-alpha; Vancomycin

2023
Echinacoside, a promising sortase A inhibitor, combined with vancomycin against murine models of MRSA-induced pneumonia.
    Medical microbiology and immunology, 2023, Volume: 212, Issue:6

    Topics: Animals; Bacterial Proteins; Disease Models, Animal; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Pneumonia; Staphylococcus aureus; Vancomycin

2023
    International journal of molecular sciences, 2023, Sep-27, Volume: 24, Issue:19

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fecal Microbiota Transplantation; Feces; Humans; Mice; Recurrence; Treatment Outcome; Vancomycin

2023
Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S. aureus infection with osseointegration in murine models of implant-associated osteomyelitis.
    Bone research, 2023, 10-18, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Osseointegration; Osteomyelitis; Staphylococcal Infections; Vancomycin

2023
Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection.
    Nature microbiology, 2019, Volume: 4, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cell Survival; Cephamycins; Chlorocebus aethiops; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gene Expression Regulation, Bacterial; Genes, Bacterial; Male; Mice; Mice, Inbred C57BL; Penicillin-Binding Proteins; Spores, Bacterial; Vancomycin; Vero Cells

2019
One Stone with Two Birds: Functional Gold Nanostar for Targeted Combination Therapy of Drug-Resistant
    ACS applied materials & interfaces, 2019, Sep-11, Volume: 11, Issue:36

    Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; COS Cells; Disease Models, Animal; Drug Therapy, Combination; Female; Gold; Hyperthermia, Induced; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Phototherapy; Staphylococcal Infections; Vancomycin

2019
A new small animal model for simulating a two-stage-revision procedure in implant-related methicillin-resistant Staphylococcus aureus bone infection.
    Injury, 2019, Volume: 50, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Fracture Fixation; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Tibial Fractures; Vancomycin

2019
Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Disease Models, Animal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Injections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Phage Therapy; Vancomycin; Vancomycin Resistance

2019
Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity.
    Science advances, 2019, Volume: 5, Issue:8

    Topics: Animals; Bacteria; Bacterial Proteins; Body Weight; Colitis; Disease Models, Animal; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucuronidase; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mycophenolic Acid; Up-Regulation; Vancomycin

2019
Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice.
    Journal of virology, 2019, 12-01, Volume: 93, Issue:23

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Coxsackievirus Infections; Disease Models, Animal; Enterovirus; Enterovirus Infections; HeLa Cells; Humans; Male; Mice; Mice, Inbred C57BL; Microbiota; Picornaviridae; Poliovirus; Vancomycin; Virus Replication

2019
Is Intraarticular Antibiotic Administration Effective in the Treatment of Methicillin-Resistant Staphylococcus aureus?
    Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, 2019, Volume: 86, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Cartilage, Articular; Disease Models, Animal; Hindlimb; Injections, Intra-Articular; Male; Methicillin-Resistant Staphylococcus aureus; Random Allocation; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Teicoplanin; Vancomycin; Wound Healing

2019
Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model.
    PloS one, 2019, Volume: 14, Issue:9

    Topics: Animals; Biocompatible Materials; Calcium Phosphates; Calcium Sulfate; Disease Models, Animal; Humans; Male; Osteogenesis; Osteomyelitis; Polymethyl Methacrylate; Random Allocation; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; X-Ray Microtomography

2019
Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imaging.
    PloS one, 2019, Volume: 14, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Disease Models, Animal; Female; Immunoconjugates; Mice; Mice, SCID; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2019
Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model.
    Journal of leukocyte biology, 2020, Volume: 107, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dysbiosis; Feces; Gastrointestinal Microbiome; Intestines; Lung; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Vancomycin

2020
CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection.
    PloS one, 2019, Volume: 14, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Biofilms; CRISPR-Cas Systems; Disease Models, Animal; Female; Fosfomycin; Gene Editing; Longitudinal Studies; Osteomyelitis; Rats; Rats, Sprague-Dawley; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2019
Does the induced membrane have antibacterial properties? An experimental rat model of a chronic infected nonunion.
    International orthopaedics, 2020, Volume: 44, Issue:2

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Bone Cements; Bone Transplantation; Chronic Disease; Debridement; Disease Models, Animal; Femoral Fractures; Femur; Fracture Healing; Fractures, Ununited; Gentamicins; Male; Membranes; Methicillin-Resistant Staphylococcus aureus; Polymethyl Methacrylate; Rats; Rats, Wistar; Staphylococcal Infections; Vancomycin

2020
Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant
    Antimicrobial resistance and infection control, 2019, Volume: 8

    Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; NF-kappa B; Osteomyelitis; Peptides; Rabbits; Random Allocation; Staphylococcal Infections; Tibia; Vancomycin

2019
Epinecidin-1 Protects against Methicillin Resistant
    Marine drugs, 2019, Dec-09, Volume: 17, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; C-Reactive Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Fish Proteins; Methicillin-Resistant Staphylococcus aureus; Sepsis; Staphylococcal Infections; Swine; Vancomycin

2019
Encapsulation of collagen mimetic peptide-tethered vancomycin liposomes in collagen-based scaffolds for infection control in wounds.
    Acta biomaterialia, 2020, Volume: 103

    Topics: Animals; Anti-Bacterial Agents; Biomimetic Materials; Cattle; Cell Survival; Collagen; Disease Models, Animal; Drug Liberation; Gels; Infection Control; Liposomes; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; NIH 3T3 Cells; Peptides; Rats, Sprague-Dawley; Skin; Tissue Scaffolds; Vancomycin; Wound Infection

2020
Evaluation of bacteriophage as an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus.
    PloS one, 2019, Volume: 14, Issue:12

    Topics: Animals; Bacterial Load; Bacteriophages; Combined Modality Therapy; Disease Models, Animal; Male; Prosthesis-Related Infections; Random Allocation; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2019
Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents
    BioMed research international, 2019, Volume: 2019

    Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Delayed-Action Preparations; Disease Models, Animal; Fractures, Open; Male; Mice; Mice, Inbred C57BL; Orthopedics; Osteomyelitis; Prostheses and Implants; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin

2019
New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection.
    Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; ErbB Receptors; Matrix Metalloproteinase 13; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Staphylococcal Skin Infections; Staphylococcus aureus; Surgical Wound Infection; Teicoplanin; Vancomycin; Vascular Endothelial Growth Factor A; Wound Healing

2020
Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Humans; Linezolid; Lipopolysaccharides; Methicillin-Resistant Staphylococcus aureus; Mice; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Vancomycin

2020
Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice.
    European journal of immunology, 2020, Volume: 50, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Disease Progression; DNA, Bacterial; Gastrointestinal Microbiome; Gentamicins; Glioma; Humans; Immunologic Surveillance; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Microglia; Neoplasm Transplantation; Phylogeny; Tumor Burden; Vancomycin

2020
Polyketides from marine-derived Aspergillus welwitschiae inhibit Staphylococcus aureus virulence factors and potentiate vancomycin antibacterial activity in vivo.
    Microbial pathogenesis, 2020, Volume: 143

    Topics: Animals; Anti-Bacterial Agents; Aspergillus; Biofilms; Disease Models, Animal; Drug Synergism; Larva; Methicillin-Resistant Staphylococcus aureus; Moths; Polyketides; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virulence Factors

2020
Topical vancomycin for treatment of methicillin-resistant Staphylococcus epidermidis infection in a rat spinal implant model.
    Spine deformity, 2020, Volume: 8, Issue:4

    Topics: Animals; Bacterial Load; Bone Wires; Disease Models, Animal; Drug Resistance, Bacterial; Female; Methicillin Resistance; Microspheres; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Rats, Sprague-Dawley; Spine; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin

2020
The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Feces; Fidaxomicin; Gastrointestinal Microbiome; Humans; Mice; Microbiota; RNA, Ribosomal, 16S; Vancomycin

2020
Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea.
    Yonsei medical journal, 2020, Volume: 61, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drugs, Generic; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Republic of Korea; Staphylococcal Infections; Staphylococcus aureus; Thigh; Treatment Failure; Vancomycin

2020
Microbe-Derived Butyrate and Its Receptor, Free Fatty Acid Receptor 3, But Not Free Fatty Acid Receptor 2, Mitigate Neointimal Hyperplasia Susceptibility After Arterial Injury.
    Journal of the American Heart Association, 2020, 07-07, Volume: 9, Issue:13

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyric Acid; Cell Movement; Cell Proliferation; Disease Models, Animal; Femoral Artery; Gastrointestinal Microbiome; Hyperplasia; Mice, Inbred C57BL; Mice, Knockout; Neointima; Receptors, G-Protein-Coupled; Signal Transduction; Vancomycin; Vascular System Injuries

2020
2020 John Charnley Award: The antimicrobial potential of bacteriophage-derived lysin in a murine debridement, antibiotics, and implant retention model of prosthetic joint infection.
    The bone & joint journal, 2020, Volume: 102-B, Issue:7_Supple_B

    Topics: Animals; Anti-Bacterial Agents; Bacteriolysis; Bacteriophages; Biofilms; Colony Count, Microbial; Debridement; Disease Models, Animal; Enzymes; In Vitro Techniques; Mice, Inbred C57BL; Prosthesis-Related Infections; Staphylococcal Infections; Vancomycin

2020
Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus.
    BMC microbiology, 2020, 07-09, Volume: 20, Issue:1

    Topics: Animals; Bacterial Load; Diabetes Mellitus, Experimental; Diabetic Foot; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Male; Mice; Phage Therapy; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wound Healing; Wound Infection

2020
Injectable Chitosan-Based Thermosensitive Hydrogel/Nanoparticle-Loaded System for Local Delivery of Vancomycin in the Treatment of Osteomyelitis.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Animals; Anti-Bacterial Agents; Cell Proliferation; Chitosan; Disease Models, Animal; Drug Delivery Systems; Hydrogels; Injections; Male; Nanoparticles; Osteoblasts; Osteomyelitis; Particle Size; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2020
Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis.
    The Journal of infectious diseases, 2020, 10-01, Volume: 222, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Foreign Bodies; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rats; Rats, Wistar; Rifabutin; Rifampin; Staphylococcal Infections; Vancomycin

2020
Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Disease Models, Animal; Drug Repositioning; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Mice; Microbial Sensitivity Tests; Ronidazole; Vancomycin; Veterinary Drugs

2020
Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice.
    Critical care (London, England), 2020, 10-15, Volume: 24, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dysbiosis; Immunosuppression Therapy; Lung; Mice, Inbred C57BL; Microbiota; Pneumonia; Pseudomonas aeruginosa; Vancomycin

2020
Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile.
    Gastroenterology, 2021, Volume: 160, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Drug Resistance, Bacterial; Germ-Free Life; Humans; Mice; Microbial Sensitivity Tests; Plasmids; Vancomycin; Whole Genome Sequencing

2021
Housefly Phormicin inhibits Staphylococcus aureus and MRSA by disrupting biofilm formation and altering gene expression in vitro and in vivo.
    International journal of biological macromolecules, 2021, Jan-15, Volume: 167

    Topics: Aldehyde Oxidoreductases; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Biofilms; Body Weight; Cell Survival; Disease Models, Animal; Gene Expression Regulation, Bacterial; Houseflies; Humans; Larva; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; RNA, Bacterial; Sigma Factor; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2021
Antibiotic Treatment in an Animal Model of Inflammatory Lung Disease.
    Methods in molecular biology (Clifton, N.J.), 2021, Volume: 2223

    Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Asthma; B-Lymphocytes; Bronchoalveolar Lavage Fluid; Dendritic Cells; Disease Models, Animal; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukin-5; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Microbiota; Papain; Staining and Labeling; T-Lymphocytes; Vancomycin

2021
Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Adoptive Transfer; Animals; Autoimmunity; B-Lymphocytes, Regulatory; Biomarkers; Disease Models, Animal; Disease Susceptibility; DNA, Bacterial; Female; Gastrointestinal Microbiome; Immunomodulation; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Severity of Illness Index; Vancomycin

2020
Comparison of two fluorescent probes in preclinical non-invasive imaging and image-guided debridement surgery of Staphylococcal biofilm implant infections.
    Scientific reports, 2021, 01-15, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Fluorescent Dyes; Mice; Optical Imaging; Prostheses and Implants; Prosthesis-Related Infections; Spinal Cord; Staphylococcus aureus; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Vancomycin

2021
In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against
    Toxins, 2021, 01-23, Volume: 13, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gliotoxin; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin

2021
Evaluation of wound healing efficiency of vancomycin-loaded electrospun chitosan/poly ethylene oxide nanofibers in full thickness wound model of rat.
    International journal of biological macromolecules, 2021, Apr-30, Volume: 177

    Topics: Animals; Anti-Bacterial Agents; Bandages; Chitosan; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Ethylene Oxide; Fibroblasts; Male; Nanofibers; Polyethylene Glycols; Rats; Rats, Wistar; Vancomycin; Wound Healing

2021
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
    Microbiome, 2021, 02-06, Volume: 9, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Colitis; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Mice; Natural Killer T-Cells; Streptomycin; Th1 Cells; Th17 Cells; Vancomycin

2021
The Western Dietary Pattern Combined with Vancomycin-Mediated Changes to the Gut Microbiome Exacerbates Colitis Severity and Colon Tumorigenesis.
    Nutrients, 2021, Mar-09, Volume: 13, Issue:3

    Topics: Animal Feed; Animals; Carcinogenesis; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Diet, Western; Disease Models, Animal; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Vancomycin

2021
Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect.
    Scientific reports, 2021, 05-13, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Regeneration; Disease Models, Animal; Drug Delivery Systems; Durapatite; Gentamicins; Osteogenesis; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; Vancomycin; X-Ray Microtomography

2021
Effects of Vancomycin on Persistent Pain-Stimulated and Pain-Depressed Behaviors in Female Fischer Rats With or Without Voluntary Access to Running Wheels.
    The journal of pain, 2021, Volume: 22, Issue:11

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Behavior, Animal; Disease Models, Animal; Female; Gastrointestinal Microbiome; Inflammation; Motor Activity; Pain; Rats, Inbred F344; Vancomycin

2021
Early Life Antibiotics Influence In Vivo and In Vitro Mouse Intestinal Epithelium Maturation and Functioning.
    Cellular and molecular gastroenterology and hepatology, 2021, Volume: 12, Issue:3

    Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; Enterocytes; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Intestines; Metronidazole; Mice; Oligonucleotide Array Sequence Analysis; Permeability; Postnatal Care; Vacuoles; Vancomycin

2021
Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
    Journal of nanobiotechnology, 2021, Aug-04, Volume: 19, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Carriers; Escherichia coli; Male; Metal-Organic Frameworks; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nanoparticle Drug Delivery System; Nanoparticles; Pseudomonas aeruginosa; RAW 264.7 Cells; Staphylococcus aureus; Vancomycin

2021
Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides.
    The Journal of infectious diseases, 2017, 03-15, Volume: 215, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Cytokines; Disease Models, Animal; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin

2017
Bone penetrance of locally administered vancomycin powder in a rat femur fracture model.
    Injury, 2017, Volume: 48, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Debridement; Disease Models, Animal; Femoral Fractures; Femur; Fractures, Open; Powders; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Surgical Wound Infection; Vancomycin

2017
D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus.
    The Journal of antibiotics, 2017, Volume: 70, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bombyx; Cycloserine; Disease Models, Animal; Drug Synergism; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2017
Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.
    Injury, 2017, Volume: 48, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Carriers; Fractures, Open; Polymethyl Methacrylate; Rats; Rats, Inbred Lew; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wound Infection

2017
Characterization of Chicken IgY Specific to
    Frontiers in cellular and infection microbiology, 2017, Volume: 7

    Topics: Adhesins, Bacterial; Administration, Oral; Animals; Antibodies, Bacterial; Bacterial Proteins; Caco-2 Cells; Chickens; Clostridioides difficile; Clostridium Infections; Colon; Diarrhea; Disease Models, Animal; Drug Combinations; Feces; Humans; Immunization, Passive; Immunoglobulin G; Immunoglobulins; Immunotherapy; Intestines; Mice; Mice, Inbred C57BL; Spores, Bacterial; Vancomycin

2017
Chronic Exposure to Subtherapeutic Antibiotics Aggravates Ischemic Stroke Outcome in Mice.
    EBioMedicine, 2017, Volume: 24

    Topics: Animals; Anti-Bacterial Agents; Brain Ischemia; Chlortetracycline; Disease Models, Animal; Endothelial Progenitor Cells; Mice; Neovascularization, Physiologic; Penicillins; Stroke; Vancomycin

2017
Ultrasound Microbubbles Enhance the Activity of Vancomycin Against Staphylococcus epidermidis Biofilms In Vivo.
    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2018, Volume: 37, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Combined Modality Therapy; Disease Models, Animal; Microbubbles; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Ultrasonic Therapy; Vancomycin

2018
CP and CP-PGN protect mice against MRSA infection by inducing M1 macrophages.
    Scientific reports, 2017, 12-04, Volume: 7, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Corynebacterium; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Kaplan-Meier Estimate; Macrophages; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Peptidoglycan; Phagocytosis; RAW 264.7 Cells; RNA Interference; RNA, Small Interfering; Staphylococcal Infections; Toll-Like Receptor 2; Vancomycin

2017
Intraoperative Vancomycin Powder Reduces Staphylococcus aureus Surgical Site Infections and Biofilm Formation on Fixation Implants in a Rabbit Model.
    Journal of orthopaedic trauma, 2018, Volume: 32, Issue:5

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Intraoperative Period; Methicillin-Resistant Staphylococcus aureus; Powders; Prostheses and Implants; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Surgical Wound Infection; Tibia; Vancomycin

2018
Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Models, Animal; Feces; Female; Fidaxomicin; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S; Vancomycin

2018
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.
    JCI insight, 2018, 02-22, Volume: 3, Issue:4

    Topics: Adult; Aged; Animals; Bacteria; CD8 Antigens; Cell Line, Tumor; Cohort Studies; Dendritic Cells; Disease Models, Animal; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Hematopoietic Stem Cell Transplantation; Host Microbial Interactions; Humans; Immunotherapy, Adoptive; Interleukin-12; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neomycin; Neoplasms; T-Lymphocytes; Treatment Outcome; Vancomycin

2018
Antibiotic-mediated bacteriome depletion in Apc
    Cancer medicine, 2018, Volume: 7, Issue:5

    Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Anti-Bacterial Agents; Colon; Disease Models, Animal; Disease Progression; Gastrointestinal Microbiome; Goblet Cells; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neomycin; Streptomycin; Vancomycin

2018
Local Delivery of Amikacin and Vancomycin from Chitosan Sponges Prevent Polymicrobial Implant-Associated Biofilm.
    Military medicine, 2018, 03-01, Volume: 183, Issue:suppl_1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Coinfection; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Vancomycin

2018
Topical rifampin powder for orthopedic trauma part I: Rifampin powder reduces recalcitrant infection in a delayed treatment musculoskeletal trauma model.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2018, Volume: 36, Issue:12

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Musculoskeletal System; Polymethyl Methacrylate; Powders; Rats; Rats, Inbred Lew; Rifampin; Staphylococcal Infections; Time-to-Treatment; Vancomycin

2018
JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
    Toxicology letters, 2018, Oct-01, Volume: 295

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Cytoprotection; Disease Models, Animal; Gene Expression Regulation; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 2; Oxidative Stress; Peptides, Cyclic; Rats, Wistar; Renal Elimination; Vancomycin

2018
Commensal bacteria aggravate allergic asthma via NLRP3/IL-1β signaling in post-weaning mice.
    Journal of autoimmunity, 2018, Volume: 93

    Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Epithelial Cells; Gene Expression; Interleukin-1beta; Lung; Macrophages, Peritoneal; Metronidazole; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; NLR Family, Pyrin Domain-Containing 3 Protein; Ovalbumin; Signal Transduction; Symbiosis; Vancomycin; Weaning

2018
Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
    The Journal of antimicrobial chemotherapy, 2018, 12-01, Volume: 73, Issue:12

    Topics: Animals; Anti-Infective Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Bacteriolysis; Blood; Daptomycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Recombinant Fusion Proteins; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin

2018
Intrawound Vancomycin Powder Reduces Bacterial Load in Contaminated Open Fracture Model.
    Journal of orthopaedic trauma, 2018, Volume: 32, Issue:10

    Topics: Animals; Debridement; Disease Models, Animal; Femoral Fractures; Fractures, Open; Humans; Intraoperative Care; Powders; Random Allocation; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Statistics, Nonparametric; Surgical Wound Infection; Treatment Outcome; Vancomycin

2018
Increased Iron Availability Aggravates the Infection of Escherichia coli O157:H7 in Mice.
    Biological trace element research, 2019, Volume: 190, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Iron; Male; Mice; Mice, Inbred C57BL; Streptomycin; Vancomycin

2019
Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Female; Linezolid; Lung; Mice, Inbred BALB C; Neutropenia; Oxazolidinones; Pneumonia, Staphylococcal; Protein Synthesis Inhibitors; Tetrazoles; Treatment Outcome; Vancomycin

2019
Colonic M1 macrophage is associated with the prolongation of gastrointestinal motility and obesity in mice treated with vancomycin.
    Molecular medicine reports, 2019, Volume: 19, Issue:4

    Topics: Animals; B7-1 Antigen; Biomarkers; Colon; Cytokines; Disease Models, Animal; Female; Gastrointestinal Motility; Immunohistochemistry; Macrophages; Mice; Obesity; Tetraspanin 30; Vancomycin

2019
The synergistic therapeutic efficacy of vancomycin and omega-3 fatty acids alleviates Staphylococcus aureus-induced osteomyelitis in rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 111

    Topics: Animals; Catalase; Disease Models, Animal; Drug Synergism; Fatty Acids, Omega-3; Glutathione; Glutathione Peroxidase; Interleukin-6; Lipid Peroxidation; Male; Osteomyelitis; Oxidative Stress; Rats; Staphylococcal Infections; Staphylococcus aureus; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Vancomycin

2019
Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection.
    Journal of visualized experiments : JoVE, 2019, 03-14, Issue:145

    Topics: Animals; Bone and Bones; Bone Diseases; Calcium Sulfate; Disease Models, Animal; Male; Rabbits; Vancomycin

2019
Early-life vancomycin treatment promotes airway inflammation and impairs microbiome homeostasis.
    Aging, 2019, 04-13, Volume: 11, Issue:7

    Topics: Allergens; Animals; Animals, Newborn; Anti-Bacterial Agents; Asthma; Disease Models, Animal; Female; Homeostasis; Inflammation; Lung; Male; Mice; Mice, Inbred C57BL; Microbiota; Ovalbumin; Pregnancy; Prenatal Exposure Delayed Effects; RNA, Ribosomal, 16S; Vancomycin

2019
Colistin-glycopeptide combinations against multidrug-resistant
    Future microbiology, 2019, Volume: 14

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Glycopeptides; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia; Survival Rate; Teicoplanin; Vancomycin

2019
Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Toxins; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Healthcare-Associated Pneumonia; Hemolysin Proteins; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Pneumonia, Staphylococcal; Vancomycin; Virulence Factors

2019
Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Coinfection; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Immunologic Factors; Influenza A virus; Influenza, Human; Interleukins; Linezolid; Lung; Mice; Mice, Inbred C57BL; Oxazolidinones; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Viral Load; Weight Loss

2013
Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.
    BMC ophthalmology, 2013, Mar-11, Volume: 13

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Colony Count, Microbial; Disease Models, Animal; Electroretinography; Endophthalmitis; Immunization, Passive; Pneumococcal Infections; Pneumococcal Vaccines; Rabbits; Streptococcus pneumoniae; Streptolysins; Vancomycin

2013
Early vancomycin, amikacin and gentamicin concentrations in pulmonary artery and pulmonary tissue are not affected by VA ECMO (venoarterial extracorporeal membrane oxygenation) in a pig model of prolonged cardiac arrest.
    Pulmonary pharmacology & therapeutics, 2013, Volume: 26, Issue:6

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Heart Arrest; Lung; Pulmonary Artery; Swine; Time Factors; Tissue Distribution; Vancomycin

2013
Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.
    The Journal of infectious diseases, 2013, Volume: 208, Issue:1

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Chemokine CCL2; Disease Models, Animal; Exotoxins; Hemolysin Proteins; Interleukin-8; Leukocidins; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Rabbits; Vancomycin

2013
Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Catheter-Related Infections; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Peptidomimetics; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin

2013
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Cornea, 2013, Volume: 32, Issue:7

    Topics: Acetamides; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Colony Count, Microbial; Colony-Forming Units Assay; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Ophthalmic Solutions; Oxazolidinones; Rabbits; Staphylococcal Infections; Vancomycin

2013
MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colon; Diarrhea; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoroquinolones; Germ-Free Life; Kaplan-Meier Estimate; Pyrimidinones; Severity of Illness Index; Swine; Treatment Outcome; Vancomycin

2013
Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Acetamides; Animals; Chicago; Disease Models, Animal; Disease Outbreaks; Disk Diffusion Antimicrobial Tests; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Humans; Kaplan-Meier Estimate; Linezolid; Moths; Oxazolidinones; Time Factors; Vancomycin; Vancomycin Resistance

2013
Ozone therapy as an adjunct to vancomycin enhances bacterial elimination in methicillin resistant Staphylococcus aureus mediastinitis.
    The Journal of surgical research, 2013, Volume: 185, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Combined Modality Therapy; Disease Models, Animal; Humans; Mediastinitis; Methicillin-Resistant Staphylococcus aureus; Ozone; Random Allocation; Rats; Rats, Wistar; Staphylococcal Infections; Sternum; Surgical Wound Infection; Treatment Outcome; Vancomycin

2013
Local antibiotic delivery by a bioabsorbable gel is superior to PMMA bead depot in reducing infection in an open fracture model.
    Journal of orthopaedic trauma, 2014, Volume: 28, Issue:6

    Topics: Absorbable Implants; Administration, Topical; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Carriers; Femoral Fractures; Fractures, Open; Gels; Gentamicins; Polymethyl Methacrylate; Rats; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Tobramycin; Vancomycin

2014
Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:10

    Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Bacterial Load; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Eye Infections, Bacterial; Keratitis; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Vancomycin

2013
Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin.
    Nature communications, 2013, Volume: 4

    Topics: Animals; Anti-Bacterial Agents; Benzenesulfonates; Biocompatible Materials; Cadaver; Diagnostic Imaging; Disease Models, Animal; Fluorescent Dyes; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Image Interpretation, Computer-Assisted; Indoles; Mice; Myositis; Time Factors; Vancomycin

2013
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin

2014
An anti-infection tissue-engineered construct delivering vancomycin: its evaluation in a goat model of femur defect.
    International journal of medical sciences, 2013, Volume: 10, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Bone Transplantation; Disease Models, Animal; Femur; Fibrin; Goats; Humans; Staphylococcus aureus; Tissue Engineering; Transplants; Vancomycin; Wound Healing

2013
Establishment of a new methicillin resistant Staphylococcus aureus animal model of osteomyelitis.
    International orthopaedics, 2014, Volume: 38, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Body Temperature; Bone Substitutes; Disease Models, Animal; Drug Resistance, Microbial; Leukocyte Count; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Staphylococcal Infections; Vancomycin

2014
Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014, Volume: 33, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Benzoates; Chelating Agents; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Iron; Kidney; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Severity of Illness Index; Spleen; Staphylococcal Infections; Treatment Outcome; Triazoles; Vancomycin

2014
Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant.
    International orthopaedics, 2014, Volume: 38, Issue:7

    Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Disease Models, Animal; Femur; Hydrogels; Male; Prostheses and Implants; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2014
Intestinal upregulation of melanin-concentrating hormone in TNBS-induced enterocolitis in adult zebrafish.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Administration, Rectal; Animals; Cell Movement; Cytokines; Disease Models, Animal; Enterocolitis; Fish Proteins; Gene Expression Regulation; Humans; Hypothalamic Hormones; Intestinal Mucosa; Intestines; Male; Melanins; Microbiota; Peroxidase; Pituitary Hormones; Receptors, Pituitary Hormone; Survival Analysis; Trinitrobenzenesulfonic Acid; Vancomycin; Zebrafish

2013
Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.
    The Journal of infection, 2014, Volume: 68, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biofilms; Catheter-Related Infections; Daptomycin; Disease Models, Animal; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2014
A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Borates; Compressive Strength; Disease Models, Animal; Drug Carriers; Glass; Kinetics; Materials Testing; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Staphylococcal Infections; Vancomycin

2014
Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.
    The Journal of infectious diseases, 2014, Sep-01, Volume: 210, Issue:5

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Antigens, Ly; Bacterial Load; Cytokines; Disease Models, Animal; Endothelial Cells; Immunologic Factors; Injections, Subcutaneous; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Neutrophils; Oxazolidinones; Peroxidase; Pneumonia, Staphylococcal; Vancomycin

2014
Evaluation of antibiotic-loaded calcium phosphate bone cement in an cranium-infected experimental model.
    Neurologia medico-chirurgica, 2014, Volume: 54, Issue:8

    Topics: Abscess; Animals; Bacterial Load; Bone Cements; Bone Transplantation; Calcium Phosphates; Craniotomy; Disease Models, Animal; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Rats; Staphylococcal Infections; Surgical Wound Infection; Vancomycin

2014
Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization.
    Mucosal immunology, 2015, Volume: 8, Issue:1

    Topics: Animals; Cell Movement; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Epithelial Cells; Gram-Positive Bacteria; Humans; Inflammatory Bowel Diseases; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Receptors, CCR2; Tumor Necrosis Factor-alpha; Vancomycin

2015
Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:9

    Topics: Acetamides; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycopeptides; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2014
Vancomycin-bearing synthetic bone graft delivers rhBMP-2 and promotes healing of critical rat femoral segmental defects.
    Clinical orthopaedics and related research, 2014, Volume: 472, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Substitutes; Bone Transplantation; Chemokine CXCL12; Coated Materials, Biocompatible; Disease Models, Animal; Femoral Fractures; Femur; Fracture Healing; Hydroxyapatites; Male; Osseointegration; Polymethacrylic Acids; Prosthesis Design; Rats; Recombinant Proteins; Time Factors; Torsion, Mechanical; Vancomycin; X-Ray Microtomography

2014
Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Disease Models, Animal; Drug Resistance, Bacterial; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Vancomycin

2014
Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Animals; Bacteremia; Bacterial Translocation; beta-Lactamases; Disease Models, Animal; Endotoxemia; Enterococcus faecalis; Escherichia coli; Gram-Positive Bacterial Infections; Liver; Male; Rats; Reperfusion Injury; Vancomycin; Vancomycin Resistance

2014
A modified chronic infection model for testing treatment of Staphylococcus aureus biofilms on implants.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Disease Models, Animal; Female; Mice; Osteomyelitis; Prostheses and Implants; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2014
Intestinal and hepatic expression of cytochrome P450s and mdr1a in rats with indomethacin-induced small intestinal ulcers.
    International journal of medical sciences, 2014, Volume: 11, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Disease Models, Animal; Gene Expression; Hep G2 Cells; Humans; Indomethacin; Intestinal Diseases; Intestine, Small; Liver; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Ulcer; Vancomycin

2014
Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Bacterial Toxins; Broadly Neutralizing Antibodies; Disease Models, Animal; Drug Therapy, Combination; Female; Hemolysin Proteins; Linezolid; Mice, Inbred BALB C; Necrosis; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin

2015
An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Ampicillin; Anaerobiosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice, Inbred ICR; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Vancomycin

2015
Pharmacodynamic evaluation of the activities of six parenteral vancomycin products available in the United States.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Animals; Blood Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Infusions, Parenteral; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred Strains; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin

2015
A novel murine model of established Staphylococcal bone infection in the presence of a fracture fixation plate to study therapies utilizing antibiotic-laden spacers after revision surgery.
    Bone, 2015, Volume: 72

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Bone and Bones; Bone Diseases; Debridement; Disease Models, Animal; Female; Fracture Healing; Mice; Mice, Inbred BALB C; Osteolysis; Osteomyelitis; Polymethyl Methacrylate; Reoperation; Staphylococcal Infections; Treatment Outcome; Vancomycin; X-Ray Microtomography

2015
Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
    The Journal of infection, 2015, Volume: 70, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Humans; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tigecycline; Vancomycin

2015
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:6

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzimidazoles; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fidaxomicin; Gastrointestinal Tract; Mesocricetus; Microbial Sensitivity Tests; Plasma; Pyridines; Recurrence; Survival Analysis; Treatment Outcome; Vancomycin

2015
Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model.
    Current eye research, 2016, Volume: 41, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Intravitreal Injections; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Vancomycin

2016
Efficacy of linezolid, teicoplanin, and vancomycin in prevention of an experimental polytetrafluoroethylene graft infection model caused by methicillin-resistant Staphylococcus aureus.
    Medical science monitor : international medical journal of experimental and clinical research, 2015, Mar-27, Volume: 21

    Topics: Animals; C-Reactive Protein; Disease Models, Animal; Leukocytes; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Polytetrafluoroethylene; Prealbumin; Prosthesis-Related Infections; Rats, Wistar; Teicoplanin; Treatment Outcome; Vancomycin

2015
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss

2015
Cathodic Electrical Stimulation Combined With Vancomycin Enhances Treatment of Methicillin-resistant Staphylococcus aureus Implant-associated Infections.
    Clinical orthopaedics and related research, 2015, Volume: 473, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Arthroplasty, Replacement; Bacterial Load; Colony Count, Microbial; Combined Modality Therapy; Disease Models, Animal; Electric Stimulation Therapy; Electrodes; Equipment Design; Humeral Head; Joint Prosthesis; Male; Methicillin-Resistant Staphylococcus aureus; Prosthesis Design; Prosthesis-Related Infections; Rats, Long-Evans; Staphylococcal Infections; Synovial Fluid; Time Factors; Titanium; Vancomycin

2015
In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Glycopeptides; Kidney Function Tests; Liver Function Tests; Methicillin-Resistant Staphylococcus aureus; Mice; Muscles; Staphylococcal Infections; Vancomycin

2015
Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole.
    The Journal of infectious diseases, 2015, Nov-15, Volume: 212, Issue:10

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Clostridioides difficile; Disease Models, Animal; Disease Resistance; Escherichia coli; Female; Klebsiella pneumoniae; Metronidazole; Mice, Inbred C57BL; Vancomycin; Vancomycin-Resistant Enterococci

2015
Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model.
    Genetics and molecular research : GMR, 2015, May-25, Volume: 14, Issue:2

    Topics: Ampicillin; Animals; CD8-Positive T-Lymphocytes; Cell Proliferation; Cisplatin; Disease Models, Animal; Humans; Inflammation; Lactobacillus; Lung Neoplasms; Mice; Microbiota; Neomycin; Neoplasm Proteins; Probiotics; Vancomycin

2015
Nanoparticle biointerfacing by platelet membrane cloaking.
    Nature, 2015, Oct-01, Volume: 526, Issue:7571

    Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Blood Vessels; Cell Membrane; Collagen; Complement Activation; Coronary Restenosis; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Humans; Macrophages; Male; Mice; Nanoparticles; Platelet Adhesiveness; Polymers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Taxoids; Unilamellar Liposomes; Vancomycin

2015
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin

2015
Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria.
    Angewandte Chemie (International ed. in English), 2015, Nov-09, Volume: 54, Issue:46

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Cell Membrane; Cell Wall; Disease Models, Animal; Dose-Response Relationship, Drug; Glycopeptides; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Vancomycin; Vancomycin Resistance

2015
In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
    Infectious diseases (London, England), 2016, Volume: 48, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Larva; Moths; Vancomycin

2016
Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Male; Mediastinitis; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rats; Spleen; Staphylococcal Infections; Sternum; Teicoplanin; Treatment Outcome; Vancomycin; Wound Infection

2016
3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection.
    European cells & materials, 2015, Nov-04, Volume: 30

    Topics: Animals; Anti-Bacterial Agents; Bone Cements; Bone Diseases; Ceramics; Disease Models, Animal; Mice; Osteomyelitis; Printing, Three-Dimensional; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2015
Pathological-Condition-Driven Construction of Supramolecular Nanoassemblies for Bacterial Infection Detection.
    Advanced materials (Deerfield Beach, Fla.), 2016, Jan-13, Volume: 28, Issue:2

    Topics: Animals; Bacterial Infections; Chlorophyll; Contrast Media; Disease Models, Animal; Escherichia coli; Gelatinases; Mice; Models, Biological; Molecular Structure; Myositis; Nanostructures; Phantoms, Imaging; Photoacoustic Techniques; Proteus vulgaris; Staphylococcus aureus; Staphylococcus epidermidis; Tomography; Vancomycin; Water

2016
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.
    Antimicrobial agents and chemotherapy, 2015, Dec-14, Volume: 60, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Debridement; Disease Models, Animal; Drug Carriers; Durapatite; Humans; Osteomyelitis; Polyethylene Glycols; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2015
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:4

    Topics: Algorithms; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Models, Theoretical; Monte Carlo Method; Neonatal Sepsis; Rabbits; Staphylococcal Infections; Staphylococcus; Vancomycin

2016
Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.
    Macromolecular bioscience, 2016, Volume: 16, Issue:4

    Topics: Acetates; Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Catheters; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Drug Liberation; Freeze Drying; Humans; Mice; Polytetrafluoroethylene; Pseudomonas aeruginosa; Skin; Staphylococcus aureus; Vancomycin

2016
Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model.
    Clinical orthopaedics and related research, 2016, Volume: 474, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Combined Modality Therapy; Disease Models, Animal; Drug Administration Schedule; Electric Stimulation Therapy; Electrodes; Humerus; Male; Methicillin-Resistant Staphylococcus aureus; Prosthesis Design; Prosthesis-Related Infections; Rats, Long-Evans; Staphylococcal Infections; Time Factors; Titanium; Vancomycin

2016
New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Models, Biological; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2016
Editorial: Vancomycin, bone growth, and wound healing.
    Journal of neurosurgery. Spine, 2016, Volume: 25, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bone Development; Disease Models, Animal; Humans; Spinal Fusion; Spine; Surgical Wound Infection; Vancomycin; Wound Healing

2016
The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.
    Journal of neurosurgery. Spine, 2016, Volume: 25, Issue:2

    Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Bone Development; Bone Morphogenetic Protein 2; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Female; Lumbar Vertebrae; Powders; Rats, Sprague-Dawley; Recombinant Proteins; Spinal Fusion; Surgical Wound; Surgical Wound Infection; Transforming Growth Factor beta; Treatment Outcome; Vancomycin; Wound Healing

2016
Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Pathogens and disease, 2016, Volume: 74, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Linezolid; Mice; Microbial Sensitivity Tests; Osteomyelitis; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2016
Vancomycin-sensitive bacteria trigger development of colitis-associated colon cancer by attracting neutrophils.
    Scientific reports, 2016, Apr-06, Volume: 6

    Topics: Animals; Azoxymethane; Bacteria; Colitis; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Humans; Mice; Neutrophils; Vancomycin

2016
Exposure to Hyperbaric Oxygen Intensified Vancomycin-Induced Nephrotoxicity in Rats.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Hyperbaric Oxygenation; Kidney; Kidney Diseases; Kidney Function Tests; Magnesium; Male; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Vancomycin

2016
Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.
    Journal of orthopaedic surgery and research, 2016, Apr-27, Volume: 11, Issue:1

    Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Implants; Fluorodeoxyglucose F18; Male; Microbial Sensitivity Tests; Osteomyelitis; Polyglactin 910; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2016
Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Enterotoxins; Female; Immunoglobulins, Intravenous; Immunologic Factors; Male; Rabbits; Sepsis; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin

2016
Time-Dependent Effectiveness of Locally Applied Vancomycin Powder in a Contaminated Traumatic Orthopaedic Wound Model.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Debridement; Disease Models, Animal; Femoral Fractures; Femur; Fractures, Open; Microspheres; Polymethyl Methacrylate; Powders; Rats; Rats, Inbred Lew; Staphylococcal Infections; Staphylococcus aureus; Therapeutic Irrigation; Time Factors; Vancomycin; Wound Infection

2016
Comparative efficacy of telavancin and daptomycin in experimental endocarditis due to multi-clonotype MRSA strains.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Vancomycin

2016
In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.
    The Journal of bone and joint surgery. American volume, 2016, Jul-20, Volume: 98, Issue:14

    Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Mice; Minocycline; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Tigecycline; Vancomycin

2016
Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:11

    Topics: Adenocarcinoma; Ampicillin; Anastomosis, Surgical; Animals; Anti-Bacterial Agents; Barrett Esophagus; Disease Models, Animal; DNA, Bacterial; DNA, Ribosomal; Esophageal Neoplasms; Esophagus; Gastroesophageal Reflux; Jejunum; Male; Metronidazole; Microbiota; Neomycin; Penicillin G; Polymorphism, Restriction Fragment Length; Random Allocation; Rats; Rats, Wistar; Streptomycin; Vancomycin

2016
Systemic and Local Administration of Antimicrobial and Cell Therapies to Prevent Methicillin-Resistant Staphylococcus epidermidis-Induced Femoral Nonunions in a Rat Model.
    Mediators of inflammation, 2016, Volume: 2016

    Topics: Animals; Anti-Bacterial Agents; Bone Marrow Cells; Cell- and Tissue-Based Therapy; Cells, Cultured; Disease Models, Animal; Femoral Fractures; Hydrogel, Polyethylene Glycol Dimethacrylate; Imidazoles; Male; Methicillin Resistance; Rats; Rats, Wistar; Staphylococcus epidermidis; Stem Cells; Vancomycin

2016
Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Antitoxins; Bacterial Proteins; Bacterial Toxins; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Convalescence; Cricetulus; Disease Models, Animal; Disease Progression; Enterotoxins; Gastrointestinal Microbiome; Humans; Mice; Mice, Inbred C57BL; Survival Analysis; Vancomycin

2016
Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bone Wires; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Foreign Bodies; Injections, Intraperitoneal; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Osteomyelitis; Oxazoles; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tibia; Vancomycin

2016
Liver steatosis induced by small bowel resection is prevented by oral vancomycin.
    Surgery, 2016, Volume: 160, Issue:6

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Disease Models, Animal; Fatty Liver; Feces; Humans; Intestine, Small; Mice; Mice, Inbred C57BL; Short Bowel Syndrome; Vancomycin

2016
Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.
    ACS infectious diseases, 2016, 02-12, Volume: 2, Issue:2

    Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Cell Membrane; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Structure-Activity Relationship; Vancomycin

2016
IVIG-mediated protection against necrotizing pneumonia caused by MRSA.
    Science translational medicine, 2016, 09-21, Volume: 8, Issue:357

    Topics: Acute Lung Injury; Animals; Antibiotic Prophylaxis; Antibodies, Neutralizing; Bacterial Toxins; Disease Models, Animal; Exotoxins; Hemolysin Proteins; Humans; Immunoglobulins, Intravenous; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Necrotizing; Rabbits; Vancomycin

2016
Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.
    Virulence, 2017, 08-18, Volume: 8, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Disease Models, Animal; Enterotoxins; Female; Humans; Immunization, Passive; Mice; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2017
The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with
    Frontiers in cellular and infection microbiology, 2016, Volume: 6

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Antitoxins; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gastrointestinal Microbiome; Longitudinal Studies; Mice; Survival Analysis; Treatment Outcome; Vancomycin

2016
Vancomycin microspheres reduce postoperative spine infection in an in vivo rabbit model.
    BMC pharmacology & toxicology, 2016, 11-29, Volume: 17, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Microspheres; Rabbits; Random Allocation; Spinal Cord; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin

2016
Vancomycin pre-treatment impairs tissue healing in experimental colitis: Importance of innate lymphoid cells.
    Biochemical and biophysical research communications, 2017, 01-29, Volume: 483, Issue:1

    Topics: Animals; Colitis; Colon; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Immunity, Innate; Interleukin-22; Interleukin-23; Interleukins; Intestinal Mucosa; Lymphocytes; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; STAT3 Transcription Factor; Vancomycin

2017
Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Enterococcus; Female; Gram-Positive Bacterial Infections; Linezolid; Mice; Mice, Inbred C57BL; Peritonitis; Vancomycin

2017
Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
    International journal of antimicrobial agents, 2016, Volume: 48, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Foreign Bodies; Methicillin Resistance; Mice, Inbred C57BL; Microbial Sensitivity Tests; Random Allocation; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin

2016
Intra-Articular Vancomycin Powder Eliminates Methicillin-Resistant S. aureus in a Rat Model of a Contaminated Intra-Articular Implant.
    The Journal of bone and joint surgery. American volume, 2017, Feb-01, Volume: 99, Issue:3

    Topics: Animals; Disease Models, Animal; Female; Methicillin-Resistant Staphylococcus aureus; Powders; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin

2017
Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
    The Journal of antibiotics, 2017, Volume: 70, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bombyx; Ceftriaxone; Disease Models, Animal; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2017
Combinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infection.
    PloS one, 2017, Volume: 12, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Prostheses and Implants; Spine; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2017
A Genetic Screen Reveals Novel Targets to Render
    Frontiers in cellular and infection microbiology, 2017, Volume: 7

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Caenorhabditis elegans; Cell Wall; Disease Models, Animal; DNA Transposable Elements; Gene Knockout Techniques; Genetic Complementation Test; Genetic Testing; Mice, Inbred C57BL; Microbial Viability; Muramidase; Mutagenesis, Insertional; Pseudomonas aeruginosa; Pseudomonas Infections; Vancomycin; Virulence

2017
The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
    Current eye research, 2008, Volume: 33, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Choroid Diseases; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Injections; Iridocyclitis; Rabbits; Treatment Outcome; Vancomycin; Vasculitis; Vitreous Body

2008
Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Male; Mediastinitis; Osteomyelitis; Rats; Reproducibility of Results; Staphylococcal Infections; Staphylococcus aureus; Sternum; Surgical Wound Infection; Vancomycin

2008
Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Aortic Valve; Aza Compounds; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin

2009
A mouse model of Clostridium difficile-associated disease.
    Gastroenterology, 2008, Volume: 135, Issue:6

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Disease Models, Animal; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Mice; Mice, Inbred C57BL; Severity of Illness Index; Vancomycin

2008
Comparison of the therapeutic efficacy of linezolid and vancomycin and correlation of serum and tissue malondialdehyde and myeloperoxidase in an experimental mediastinitis model.
    The Journal of surgical research, 2009, Volume: 152, Issue:1

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Linezolid; Male; Malondialdehyde; Mediastinitis; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Peroxidase; Rats; Rats, Wistar; Vancomycin

2009
Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model.
    The Journal of infectious diseases, 2009, Feb-01, Volume: 199, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gastrointestinal Diseases; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Selection, Genetic; Vancomycin

2009
Controlled release of vancomycin from thin sol-gel films on implant surfaces successfully controls osteomyelitis.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2009, Volume: 27, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bone Density; Bone Nails; Bone Resorption; Coated Materials, Biocompatible; Disease Models, Animal; Femur; Gels; Osteogenesis; Osteomyelitis; Prosthesis-Related Infections; Radiography; Rats; Staphylococcal Infections; Staphylococcus aureus; Titanium; Vancomycin

2009
First attempt to produce experimental Campylobacter concisus infection in mice.
    World journal of gastroenterology, 2008, Dec-07, Volume: 14, Issue:45

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cyclophosphamide; Disease Models, Animal; Female; Gastrointestinal Diseases; Ileum; Immunosuppressive Agents; Injections, Intraperitoneal; Jejunum; Liver; Male; Mice; Mice, Inbred BALB C; Vancomycin; Weight Loss

2008
Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.
    The Journal of infectious diseases, 2009, Jan-15, Volume: 199, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacteriolysis; Cell Wall; Community-Acquired Infections; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Gene Expression Regulation, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Oxacillin; Rabbits; Staphylococcal Infections; Trans-Activators; Vancomycin

2009
Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model.
    The Journal of infectious diseases, 2009, Jan-15, Volume: 199, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Disease Models, Animal; Endocarditis, Bacterial; Genotype; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenotype; Rabbits; Staphylococcal Infections; Vancomycin

2009
Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Pediatric research, 2009, Volume: 65, Issue:4

    Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bacteremia; Colony Count, Microbial; Disease Models, Animal; Injections, Intraperitoneal; Lysostaphin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2009
Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Guinea Pigs; Humans; Meningitis, Pneumococcal; Meropenem; Microbial Viability; Rifampin; Streptococcus pneumoniae; Thienamycins; Time Factors; Treatment Outcome; Vancomycin

2009
Daptomycin in experimental murine pneumococcal meningitis.
    BMC infectious diseases, 2009, Apr-30, Volume: 9

    Topics: Animals; Anti-Bacterial Agents; Apoptosis; Brain; Caspase 3; Daptomycin; Dexamethasone; Disease Models, Animal; Imaging, Three-Dimensional; Meningitis, Pneumococcal; Mice; Microbial Sensitivity Tests; Vancomycin

2009
Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    The Journal of surgical research, 2009, Volume: 157, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Delivery Systems; Male; Methicillin-Resistant Staphylococcus aureus; Microspheres; Polymethyl Methacrylate; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Treatment Outcome; Vancomycin

2009
Oxazolone-induced enterocolitis in zebrafish depends on the composition of the intestinal microbiota.
    Gastroenterology, 2009, Volume: 137, Issue:5

    Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Enterocolitis; Intestines; Oxazolone; Vancomycin; Zebrafish

2009
The inhibitory effect of vancomycin ointment on the manifestation of MRSA keratitis in rabbits.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Conjunctivitis; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Keratitis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ointments; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin

2009
Telavancin.
    Drugs, 2009, Volume: 69, Issue:18

    Topics: Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Skin Diseases, Infectious; Staphylococcal Infections; Treatment Outcome; Vancomycin

2009
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Base Sequence; Disease Models, Animal; DNA Primers; DNA, Viral; Drug Synergism; Female; Genes, Viral; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Oxacillin; Protein Engineering; Recombinant Fusion Proteins; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus Phages; Vancomycin; Viral Proteins

2010
Vancomycin lung concentration in acute and hyperacute rejection models of lung transplantation in rats.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2010, Volume: 38, Issue:4

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Disease Models, Animal; Graft Rejection; Lung; Lung Transplantation; Male; Opportunistic Infections; Rats; Rats, Inbred Strains; Vancomycin

2010
Experimental intracameral injection of vancomycin microparticles in rabbits.
    Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:8

    Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Cell Count; Chromatography, High Pressure Liquid; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Endothelium, Corneal; Eye Infections, Bacterial; Half-Life; Injections; Iris; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Particle Size; Polyglactin 910; Rabbits; Retina; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

2010
Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection.
    Interactive cardiovascular and thoracic surgery, 2010, Volume: 11, Issue:1

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Colony Count, Microbial; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polyethylene Terephthalates; Prosthesis Design; Prosthesis-Related Infections; Rats; Rats, Wistar; Staphylococcal Infections; Tissue Adhesives; Tissue Distribution; Vancomycin

2010
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
    Acta ophthalmologica, 2010, Volume: 88, Issue:4

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin

2010
Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:8

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone and Bones; Bone Marrow; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Linezolid; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Oxazolidinones; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin

2010
Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drugs, Generic; Humans; Mice; Microbial Sensitivity Tests; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Therapeutic Equivalency; Thigh; Treatment Failure; Vancomycin

2010
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Acetamides; Animals; Ascitic Fluid; Bacteremia; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Imipenem; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2010
Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Synergism; Guinea Pigs; Microbial Sensitivity Tests; Polysaccharides, Bacterial; Rifampin; Staphylococcal Skin Infections; Staphylococcus epidermidis; Vancomycin; Virulence Factors

2010
Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?
    Journal of orthopaedic trauma, 2010, Volume: 24, Issue:9

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Chitosan; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fractures, Open; Goats; Infection Control; Pseudomonas Infections; Staphylococcal Infections; Vancomycin

2010
Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.
    Texas Heart Institute journal, 2010, Volume: 37, Issue:4

    Topics: Acetamides; Animals; Anti-Infective Agents; Aortic Valve; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Infusions, Intravenous; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rats; Rats, Wistar; Teicoplanin; Time Factors; Vancomycin; Virginiamycin

2010
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:1

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Female; Fosfomycin; Humans; Imipenem; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin

2011
Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bone and Bones; Bone Marrow; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Female; Joints; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rabbits; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin

2010
Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
    Investigative ophthalmology & visual science, 2011, Mar-25, Volume: 52, Issue:3

    Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections, Intravenous; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

2011
Assessing the character of the rhBMP-2- and vancomycin-loaded calcium sulphate composites in vitro and in vivo.
    Archives of orthopaedic and trauma surgery, 2011, Volume: 131, Issue:7

    Topics: Analysis of Variance; Animals; Bone Morphogenetic Protein 2; Calcium Sulfate; Cells, Cultured; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunohistochemistry; In Vitro Techniques; Male; Osteomyelitis; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia; Tissue and Organ Harvesting; Vancomycin

2011
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Humans; Mesocricetus; Metronidazole; Oxazolidinones; Spores, Bacterial; Vancomycin

2011
In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 9

    Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rodent Diseases; Saponins; Surgical Wound Infection; Treatment Outcome; Vancomycin

2011
Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia?
    Critical care medicine, 2011, Volume: 39, Issue:8

    Topics: Acetamides; Analysis of Variance; Animals; Anti-Infective Agents; Apoptosis; Confidence Intervals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunity, Innate; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutrophils; Oxazolidinones; Peroxidase; Pneumonia, Staphylococcal; Random Allocation; Survival Rate; Treatment Outcome; Vancomycin

2011
Mouse relapse model of Clostridium difficile infection.
    Infection and immunity, 2011, Volume: 79, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Neutralizing; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enterocolitis, Pseudomembranous; Enterotoxins; Mice; Mice, Inbred C57BL; Secondary Prevention; Vancomycin

2011
Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Combined Modality Therapy; Disease Models, Animal; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Leukocyte Count; Male; Neutrophils; Rabbits; Retina; Specific Pathogen-Free Organisms; Treatment Outcome; Vancomycin; Vitrectomy; Vitreous Body

2011
Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
    The Journal of infection, 2011, Volume: 63, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Foreign Bodies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Models, Animal; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tigecycline; Time Factors; Treatment Outcome; Vancomycin

2011
Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results?
    Critical care medicine, 2011, Volume: 39, Issue:8

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; Immunity, Innate; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Pneumonia, Staphylococcal; Risk Assessment; Treatment Outcome; Vancomycin

2011
Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
    Critical care medicine, 2012, Volume: 40, Issue:1

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Interleukin-6; Interleukin-8; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Respiration, Artificial; Swine; Tumor Necrosis Factor-alpha; Vancomycin

2012
Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Endocarditis, Bacterial; Gene Expression Regulation, Bacterial; Genes, Regulator; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Trans-Activators; Treatment Outcome; Vancomycin; Virulence

2011
Adding vancomycin to bone cement: research on its influence on mechanical and fixation strength using rabbit femoral prostheses.
    Orthopaedic surgery, 2011, Volume: 3, Issue:4

    Topics: Animals; Biomechanical Phenomena; Bone Cements; Disease Models, Animal; Femur; Male; Materials Testing; Prostheses and Implants; Prosthesis Design; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Stress, Mechanical; Tensile Strength; Vancomycin

2011
Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drugs, Generic; Female; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Staphylococcal Infections; Therapeutic Equivalency; Thigh; Tissue Extracts; Vancomycin

2012
Staphylococcus aureus infection induced redox signaling and DNA fragmentation in T-lymphocytes: possible ameliorative role of nanoconjugated vancomycin.
    Toxicology mechanisms and methods, 2012, Volume: 22, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Apoptosis; Catalase; Chemistry, Pharmaceutical; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Lipid Peroxidation; Male; Mice; Nanoconjugates; Nitrates; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Superoxide Dismutase; T-Lymphocytes; Time Factors; Vancomycin; Vancomycin Resistance

2012
Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Female; Humans; Liver; Methicillin Resistance; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin

2012
Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2012, Volume: 61, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Carriers; Drug Implants; Durapatite; Methicillin-Resistant Staphylococcus aureus; Nanostructures; Osteomyelitis; Rabbits; Radiography; Staphylococcal Infections; Tibia; Vancomycin

2012
Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Disease Models, Animal; Endocarditis, Bacterial; Injections, Intravenous; Rats; Selection, Genetic; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2012
A novel agent effective against Clostridium difficile infection.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Disease Models, Animal; DNA-Directed DNA Polymerase; Enterocolitis, Pseudomembranous; Female; Humans; Morpholines; Nucleic Acid Synthesis Inhibitors; Purines; Vancomycin

2012
Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Pneumonia, Staphylococcal; Survival Rate; Tetrazoles; Vancomycin

2012
Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Blood; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Culture Techniques; Disease Models, Animal; Female; Heparin; Humans; Microscopy, Electron, Scanning; Minocycline; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Time Factors; Vancomycin

2012
Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Biological Availability; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Eye; Female; Half-Life; Intravitreal Injections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Severity of Illness Index; Staphylococcal Infections; Vancomycin

2012
Critical appraisal of air pouch infection model in rats.
    Annals of clinical and laboratory science, 2012,Winter, Volume: 42, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Exudates and Transudates; Female; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin

2012
Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy.
    FEMS immunology and medical microbiology, 2012, Volume: 65, Issue:2

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Equipment and Supplies; Intubation, Intratracheal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Microscopy, Confocal; Oxazolidinones; Placebos; Pneumonia, Staphylococcal; Spain; Staining and Labeling; Swine; Vancomycin

2012
Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Female; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin

2012
Effect of negative pressure wound therapy on the elution of antibiotics from polymethylmethacrylate beads in a porcine simulated open femur fracture model.
    Journal of orthopaedic trauma, 2012, Volume: 26, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Body Fluids; Disease Models, Animal; Dosage Forms; Fasciotomy; Female; Femoral Fractures; Fractures, Open; Male; Microspheres; Negative-Pressure Wound Therapy; Polymethyl Methacrylate; Swine; Tobramycin; Treatment Outcome; Vancomycin

2012
Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzamides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enzyme Inhibitors; Fidaxomicin; Mice; Microbial Sensitivity Tests; Nitro Compounds; Pyruvate Synthase; Thiazoles; Treatment Outcome; Vancomycin

2012
Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
    Investigative ophthalmology & visual science, 2012, Jul-20, Volume: 53, Issue:8

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Electroretinography; Endophthalmitis; Female; Intravitreal Injections; Linezolid; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body

2012
[Injectable borate glass/chitosan composite as drug carrier for treatment of chronic osteomyelitis].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2012, Volume: 26, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Borates; Calcium Sulfate; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Female; Glass; Injections; Male; Materials Testing; Osteomyelitis; Rabbits; Staphylococcal Infections; Vancomycin; X-Ray Diffraction

2012
Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance

2012
Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study.
    The Journal of bone and joint surgery. American volume, 2012, Aug-01, Volume: 94, Issue:15

    Topics: Animals; Bacterial Adhesion; Biofilms; Bone Plates; Coated Materials, Biocompatible; Disease Models, Animal; Microscopy, Electron, Scanning; Osteotomy; Prosthesis-Related Infections; Sheep, Domestic; Staphylococcal Infections; Staphylococcus aureus; Stem Cells; Surface Properties; Tibia; Titanium; Vancomycin; Wound Healing; X-Ray Microtomography

2012
Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:12

    Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Cecum; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Feces; Glycopeptides; Humans; Lipoglycopeptides; Spores, Bacterial; Vancomycin

2012
Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus.
    The Journal of antibiotics, 2012, Volume: 65, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Streptomyces; Thiazoles; Time Factors; Vancomycin

2012
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
    Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:11

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Linezolid; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Staphylococcal Infections; Vancomycin

2012
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing

2013
Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.
    BMC infectious diseases, 2012, Dec-10, Volume: 12

    Topics: Animals; Anti-Bacterial Agents; Body Weight; Clostridioides difficile; Clostridium Infections; Diarrhea; Disease Models, Animal; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2A; Secondary Prevention; Survival Analysis; Vancomycin

2012
Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2013, Volume: 31, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Intercellular Signaling Peptides and Proteins; Leukocyte Count; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Platelet-Rich Plasma; Rabbits; Staphylococcal Infections; Tibia; Vancomycin

2013
Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Vancomycin

2013
Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.
    The Journal of infectious diseases, 2013, May-15, Volume: 207, Issue:10

    Topics: Animals; Apoptosis; Bacterial Proteins; Bacterial Toxins; Cell Line; Cell Proliferation; Clostridioides difficile; Clostridium Infections; Dipeptides; Disease Models, Animal; Enterocytes; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Necrosis; Rats; Vancomycin

2013
Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Linezolid; Male; Methicillin Resistance; Mice; Oxazolidinones; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2002
Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Enterococcus faecium; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Minocycline; Peritonitis; Tetracyclines; Tigecycline; Vancomycin

2003
In vitro and in vivo pharmacokinetics-pharmacodynamics of GV143253A, a novel trinem.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:2

    Topics: Animals; Area Under Curve; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Half-Life; Lactams; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2003
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:4

    Topics: Animals; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Male; Middle Aged; Rabbits; Staphylococcal Infections; Treatment Failure; Vancomycin

2003
Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Disease Models, Animal; Ertapenem; Lactams; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Vancomycin

2003
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2003
Antiendotoxin activity of antimicrobial peptides and glycopeptides.
    Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Male; Penicillins; Piperacillin; Proteins; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Teicoplanin; Vancomycin

2003
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Circulation, 2003, Aug-12, Volume: 108, Issue:6

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Glycopeptides; Implants, Experimental; Male; Microbial Sensitivity Tests; Oligopeptides; Polyethylene Terephthalates; Proteins; Rats; Rats, Wistar; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Subcutaneous Tissue; Treatment Outcome; Vancomycin; Vancomycin Resistance

2003
Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    The Journal of infectious diseases, 2004, Jan-01, Volume: 189, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gram-Positive Bacterial Infections; Heart; Promoter Regions, Genetic; Rabbits; Teicoplanin; Vancomycin; Vancomycin Resistance

2004
Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2004, Volume: 242, Issue:4

    Topics: Amikacin; Animals; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body

2004
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Peptides, 2005, Volume: 26, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Imipenem; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Random Allocation; Sensitivity and Specificity; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin

2005
Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3

    Topics: Animals; Aortic Valve; Cephalosporins; Disease Models, Animal; Endocarditis, Bacterial; Heart Valve Diseases; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2005
Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
    Biomaterials, 2005, Volume: 26, Issue:25

    Topics: Animals; Biological Availability; Body Weight; Bone Cements; C-Reactive Protein; Chronic Disease; Disease Models, Animal; Drug Carriers; Durapatite; Leukocyte Count; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2005
Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Animals; Bone and Bones; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Minocycline; Osteomyelitis; Rabbits; Radiography; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin

2005
The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    American journal of ophthalmology, 2005, Volume: 139, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefazolin; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2005
Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Disease Susceptibility; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Male; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Triamcinolone Acetonide; Vancomycin; Vitreous Body

2005
Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Aortic Valve; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Heart Valve Diseases; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2005
Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2005
Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    American journal of ophthalmology, 2005, Volume: 140, Issue:3

    Topics: Animals; Anterior Chamber; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections; Moxifloxacin; No-Observed-Adverse-Effect Level; Ophthalmic Solutions; Quinolines; Rabbits; Safety; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body

2005
Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Cerebrospinal Fluid; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Meningitis, Meningococcal; Penicillin Resistance; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin

2005
In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
    Toxicology, 2005, Nov-15, Volume: 215, Issue:3

    Topics: Acetylglucosaminidase; Administration, Oral; Animals; Anti-Bacterial Agents; Catalase; Disease Models, Animal; Drug Antagonism; Drug Therapy, Combination; Injections, Intraperitoneal; Kidney; Kidney Diseases; Kidney Tubules; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Thioglycolates; Thiophenes; Vancomycin

2005
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cecum; Clindamycin; Clostridioides difficile; Cricetinae; Depsipeptides; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gastrointestinal Contents; Male; Random Allocation; Time Factors; Vancomycin

2005
In vivo activity of mutacin B-Ny266.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5

    Topics: Animals; Bacteriocins; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2005
Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5

    Topics: Animals; Ceftriaxone; Cephalosporin Resistance; Cerebrospinal Fluid; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Female; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin

2005
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Male; Oxazolidinones; Plankton; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virginiamycin

2005
Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Male; Meningitis, Bacterial; Methicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2005
Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Amoxicillin; Animals; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Floxacillin; Male; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1989
Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Animals; Disease Models, Animal; Endocarditis, Bacterial; Fosfomycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1989
The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    The Journal of surgical research, 2005, Volume: 129, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin Resistance; Polyethylene Terephthalates; Polytetrafluoroethylene; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

2005
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cerebrospinal Fluid; Daptomycin; Disease Models, Animal; Humans; Meningitis, Bacterial; Methicillin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2006
Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Streptococcus pneumoniae; Vancomycin

2006
Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
    BMC infectious diseases, 2006, Mar-17, Volume: 6

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Blood Cell Count; Cyclophosphamide; Disease Models, Animal; Escherichia coli; Female; Immunosuppressive Agents; Leukopenia; Meningoencephalitis; Mice; Mice, Inbred ICR; Models, Animal; Neutropenia; Pneumonia, Bacterial; Random Allocation; Specific Pathogen-Free Organisms; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Vancomycin

2006
Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
    International journal of pharmaceutics, 2006, Jul-24, Volume: 317, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Chitosan; Colony Count, Microbial; Disease Models, Animal; Drug Compounding; Drug Implants; Injections, Intramuscular; Male; Methicillin Resistance; Microspheres; Osteomyelitis; Particle Size; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2006
Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:2

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteremia; Blood; Disease Models, Animal; Lipoglycopeptides; Methicillin Resistance; Mice; Spleen; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin

2006
[Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2006, Volume: 80, Issue:3

    Topics: Animals; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2006
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
    Peptides, 2006, Volume: 27, Issue:11

    Topics: Animals; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Glycopeptides; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Protein Structure, Secondary; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2006
[Effect of vancomycin-loaded polymethylmethacrylate on one-stage revision arthroplasty in treating experimental hemiprosthetic hip infections of rabbits].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2006, Volume: 20, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Femur Head; Hip Prosthesis; Polymethyl Methacrylate; Prosthesis-Related Infections; Rabbits; Vancomycin

2006
Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Lung; Male; Methicillin; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Pyrrolidines; Quinolones; Specific Pathogen-Free Organisms; Staphylococcus aureus; Vancomycin

2006
Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
    Journal of vascular surgery, 2006, Volume: 44, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Blood Vessel Prosthesis; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Male; Methicillin Resistance; Mice; Mice, Inbred C57BL; Polyesters; Polyethylene Terephthalates; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Subcutaneous Tissue; Vancomycin

2006
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2006, Volume: 11, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tibia; Tobramycin; Vancomycin

2006
Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Cloxacillin; Disease Models, Animal; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2006
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cloxacillin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Foreign-Body Reaction; Humans; Levofloxacin; Linezolid; Male; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2006
Development of a biodegradable alginate carrier system for antibiotics and bone cells.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2007, Volume: 25, Issue:1

    Topics: Alginates; Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Bone and Bones; Calcium; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Implants; Mesenchymal Stem Cell Transplantation; Organic Chemicals; Osteomyelitis; Osteopontin; Rabbits; Vancomycin

2007
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Blood Proteins; Daptomycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Microbial Sensitivity Tests; Microbial Viability; Protein Binding; Rats; Rats, Wistar; Teicoplanin; Vancomycin

2006
Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
    Spine, 2006, Oct-15, Volume: 31, Issue:22

    Topics: Acetamides; Animals; Discitis; Disease Models, Animal; Linezolid; Methicillin Resistance; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2006
RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Male; Microspheres; Oligopeptides; Polymethacrylic Acids; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2007
Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
    Chemical communications (Cambridge, England), 2007, Jan-21, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Cross-Linking Reagents; Dimerization; Disease Models, Animal; Enterococcus faecalis; Mice; Molecular Structure; Oxazines; Pneumococcal Infections; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance

2007
Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 100, Issue:5

    Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Urea Nitrogen; Caffeic Acids; Catalase; Disease Models, Animal; Drinking; Drug Combinations; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Kidney Diseases; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Vancomycin; Vitamin E; Water Supply

2007
Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2007, Volume: 34, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Blood Vessel Prosthesis; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Male; Methicillin Resistance; Polyethylene Terephthalates; Prosthesis Design; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2007
Cholesterol production inhibitor (statin) increased bone healing in surgically created femoral defect in an animal model.
    Biomedical sciences instrumentation, 2007, Volume: 43

    Topics: Animals; Anticholesteremic Agents; Disease Models, Animal; Drug Combinations; Femoral Fractures; Femur; Fracture Healing; Male; Osteogenesis; Rats; Rats, Sprague-Dawley; Simvastatin; Treatment Outcome; Vancomycin

2007
PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
    Clinical orthopaedics and related research, 2007, Volume: 462

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Colony Count, Microbial; Disease Models, Animal; Drug Carriers; Durapatite; Female; Microbial Viability; Osteomyelitis; Polymethacrylic Acids; Radiography; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Tibia; Treatment Outcome; Vancomycin

2007
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
    Peptides, 2007, Volume: 28, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Implants, Experimental; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Oligopeptides; Prosthesis-Related Infections; Rats; Rats, Wistar; Staphylococcal Skin Infections; Subcutaneous Tissue; Vancomycin

2007
Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study.
    Clinical orthopaedics and related research, 2007, Volume: 461

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Proliferation; Disease Models, Animal; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Wistar; Titanium; Vancomycin

2007
Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis.
    International orthopaedics, 2008, Volume: 32, Issue:6

    Topics: Alendronate; Animals; Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Transplantation; Disease Models, Animal; Drug Carriers; Drug Therapy, Combination; Osteomyelitis; Rats; Rats, Wistar; Vancomycin; Wound Healing

2008
Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Antioxidants; Blood Urea Nitrogen; Catalase; Creatinine; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Recombinant Proteins; Superoxide Dismutase; Vancomycin

2007
Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

2008
Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure.
    Drug metabolism and pharmacokinetics, 2007, Volume: 22, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Generic; Injections, Intravenous; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Function Tests; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Vancomycin

2007
Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin.
    The Journal of thoracic and cardiovascular surgery, 2008, Volume: 135, Issue:1

    Topics: Absorbable Implants; Administration, Topical; Animals; Anti-Bacterial Agents; Caproates; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Lactones; Male; Methicillin Resistance; Polyesters; Prosthesis-Related Infections; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2008
Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2008, Volume: 26, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Bone Nails; Coated Materials, Biocompatible; Combined Modality Therapy; Debridement; Disease Models, Animal; Drug Delivery Systems; Drug Therapy, Combination; Femoral Fractures; Gentamicins; Male; Methicillin Resistance; Osteomyelitis; Polymethyl Methacrylate; Prosthesis-Related Infections; Rabbits; Stainless Steel; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2008
Cyanoacrylate gluing increases the effectiveness of systemic antimicrobial treatment in sternal infection: experimental study in a rodent model.
    The Thoracic and cardiovascular surgeon, 2008, Volume: 56, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bone Cements; Cyanoacrylates; Disease Models, Animal; Female; Male; Methicillin Resistance; Random Allocation; Rats; Rats, Wistar; Staphylococcal Infections; Sternum; Surgical Wound Infection; Time Factors; Treatment Outcome; Vancomycin

2008
Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats.
    Acta orthopaedica, 2007, Volume: 78, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chromatography, High Pressure Liquid; Disease Models, Animal; Male; Osteomyelitis; Prosthesis-Related Infections; Rats; Rats, Wistar; Tissue Distribution; Treatment Outcome; Vancomycin

2007
Development of a mouse model of induced Staphylococcus aureus infective endocarditis.
    Comparative medicine, 2007, Volume: 57, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Aortic Valve; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Methicillin Resistance; Mice; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2007
Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
    Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Imipenem; Injections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body

2008
Toward improving therapeutic regimens for Bacillus endophthalmitis.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Biological Availability; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Glucocorticoids; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Retina; Vancomycin; Vitreous Body

2008
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vi
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Clindamycin; Colony Count, Microbial; Community-Acquired Infections; Culture Media; Daptomycin; Disease Models, Animal; Doxycycline; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2008
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
    Peptides, 2008, Volume: 29, Issue:7

    Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Proteins; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stents; Ureter; Vancomycin

2008
Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    The Journal of laboratory and clinical medicine, 1982, Volume: 100, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Cephalothin; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Gentamicins; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Vancomycin

1982
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.
    The Journal of infectious diseases, 1980, Volume: 141, Issue:1

    Topics: Absorption; Animals; Anion Exchange Resins; Anti-Bacterial Agents; Binding, Competitive; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Cricetinae; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Feces; Ion Exchange Resins; Male; Vancomycin

1980
Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Cephalothin; Cephradine; Disease Models, Animal; Leukocyte Count; Male; Meningitis; Methicillin; Nafcillin; Oxacillin; Rabbits; Staphylococcal Infections; Vancomycin

1980
Clinical and laboratory observations in Clostridium difficile colitis.
    The American journal of clinical nutrition, 1980, Volume: 33, Issue:11 Suppl

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Cricetinae; Cytotoxins; Disease Models, Animal; Enterocolitis, Pseudomembranous; Guinea Pigs; Vancomycin

1980
Antibiotic pharmacokinetics following fluid resuscitation from traumatic shock.
    Archives of surgery (Chicago, Ill. : 1960), 1995, Volume: 130, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Aztreonam; Disease Models, Animal; Female; Fluid Therapy; Hemodynamics; Male; Metabolic Clearance Rate; Shock, Hemorrhagic; Swine; Vancomycin

1995
The effect of prophylactic antibiotics on iatrogenic intervertebral disc infections. a rabbit model.
    Spine, 1995, Mar-15, Volume: 20, Issue:6

    Topics: Animals; Cefazolin; Disease Models, Animal; Iatrogenic Disease; Injections, Intravenous; Intervertebral Disc; Postoperative Complications; Rabbits; Spinal Diseases; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1995
A mouse model of implant-associated infection.
    The International journal of artificial organs, 1993, Volume: 16, Issue:11

    Topics: Animals; Catheterization; Catheters, Indwelling; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Peritoneal Cavity; Peritoneal Dialysis, Continuous Ambulatory; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

1993
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin

1993
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
    American journal of ophthalmology, 1993, Dec-15, Volume: 116, Issue:6

    Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin

1993
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:10

    Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Rifampin; Vancomycin

1993
Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
    The Journal of infectious diseases, 1993, Volume: 168, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Rabbits; Vancomycin

1993
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7

    Topics: Ampicillin; Animals; Aortic Valve; beta-Lactamases; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Rabbits; Sulbactam; Vancomycin

1993
Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection.
    The Journal of infectious diseases, 1993, Volume: 168, Issue:1

    Topics: Animals; Cefazolin; Disease Models, Animal; Female; Guinea Pigs; Male; Regression Analysis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wound Infection

1993
Comparative treatment of experimental Staphylococcus aureus endophthalmitis.
    American journal of ophthalmology, 1996, Volume: 121, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefazolin; Cephalosporins; Combined Modality Therapy; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Methylprednisolone; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitrectomy; Vitreous Body

1996
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:6

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Depsipeptides; Digestive System; Disease Models, Animal; Drug Resistance, Microbial; Enterococcus faecium; Female; Mice; Microbial Sensitivity Tests; Peptides, Cyclic; Streptomycin; Vancomycin

1996
Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Disease Models, Animal; Imipenem; Lung; Male; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Pneumonia, Pneumococcal; Species Specificity; Streptococcus pneumoniae; Vancomycin

1996
Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.
    Retina (Philadelphia, Pa.), 1996, Volume: 16, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pilot Projects; Random Allocation; Retinitis; Swine; Thienamycins; Vancomycin; Vitreous Body

1996
In-vivo activity and pharmacodynamics of cefotaxime in combination with vancomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:4

    Topics: Analysis of Variance; Animals; Cefotaxime; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Half-Life; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Rabbits; Thrombosis; Treatment Outcome; Vancomycin

1996
[Proceedings:The 2nd Japanese-United States vancomycin forum (discussion)].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:9

    Topics: Animals; Disease Models, Animal; Drug Monitoring; Humans; Japan; Methicillin Resistance; Mice; Penicillin Resistance; Pneumonia, Pneumococcal; Staphylococcal Infections; Streptococcus pneumoniae; United States; Vancomycin

1996
Treatment of osteomyelitis with a biodegradable antibiotic implant.
    Clinical orthopaedics and related research, 1997, Issue:341

    Topics: Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Disease Models, Animal; Drug Delivery Systems; Female; Lactic Acid; Osteomyelitis; Polyesters; Polymers; Rabbits; Staphylococcal Infections; Vancomycin

1997
Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
    International orthopaedics, 1997, Volume: 21, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biodegradation, Environmental; Calcium Sulfate; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Femur; Fluorescence Polarization Immunoassay; Lactic Acid; Materials Testing; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Radiography; Staphylococcal Infections; Vancomycin

1997
Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Nisin; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin

1998
High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1999, Volume: 15, Issue:1

    Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Injections, Intramuscular; Methylprednisolone; Rabbits; Retina; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body

1999
Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
    Drugs under experimental and clinical research, 1998, Volume: 24, Issue:4

    Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Area Under Curve; Bone and Bones; Chromatography, High Pressure Liquid; Disease Models, Animal; Female; Guinea Pigs; Half-Life; Injections, Intravenous; Teicoplanin; Vancomycin

1998
Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cephalosporin Resistance; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Meningitis, Pneumococcal; Outcome Assessment, Health Care; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Vancomycin

1999
Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Naphthyridines; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin

1999
Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice.
    International journal of antimicrobial agents, 1999, Volume: 12, Issue:4

    Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Interferon-gamma; Mice; Vancomycin

1999
Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:10

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin

1999
Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection.
    Magma (New York, N.Y.), 1999, Volume: 9, Issue:1-2

    Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Cilastatin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Evaluation Studies as Topic; Extremities; Histological Techniques; Imipenem; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1999
Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:12

    Topics: Animals; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Thienamycins; Vancomycin

1999
Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Peritonitis; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Vancomycin

2000
Antibiotic levels in empyemic pleural fluid.
    Chest, 2000, Volume: 117, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biological Availability; Ceftriaxone; Clindamycin; Disease Models, Animal; Empyema, Pleural; Gentamicins; Humans; Infusions, Intravenous; Metronidazole; Pasteurella Infections; Pasteurella multocida; Penicillins; Rabbits; Vancomycin

2000
Saccharomicins, novel heptadecaglycoside antibiotics produced by Saccharothrix espanaensis: antibacterial and mechanistic activities.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:8

    Topics: Actinomycetales; Aminoglycosides; Animals; Anti-Bacterial Agents; Carbohydrate Sequence; Cations; Cell Membrane; Disease Models, Animal; DNA; Drug Interactions; Female; Gram-Positive Bacterial Infections; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Biosynthesis; Proteins; Staphylococcus; Vancomycin

2000
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin

2000
Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Endocarditis, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Rabbits; Streptococcal Infections; Streptococcus; Treatment Outcome; Vancomycin

2000
Efficacy of linezolid in a staphylococcal endocarditis rabbit model.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:3

    Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Injections, Intravenous; Linezolid; Male; Oxazolidinones; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2001
Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:5

    Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae; Vancomycin; Virginiamycin

2001
Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Catheterization; Ciprofloxacin; Disease Models, Animal; Drug Stability; Drug Synergism; Drug Therapy, Combination; Heparin; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2001
Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Teicoplanin; Vancomycin

2001
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:7

    Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin

2001
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2001, Volume: 19, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin

2001
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment.
    International journal of molecular medicine, 2002, Volume: 9, Issue:1

    Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Weight; Colitis; Diet; Disease Models, Animal; Hordeum; Male; Metronidazole; Phytotherapy; Plant Preparations; Probiotics; Rats; Rats, Sprague-Dawley; Vancomycin

2002
Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gentamicins; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Treatment Outcome; Vancomycin

2002
Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:3

    Topics: Animals; Brain Edema; Cerebrospinal Fluid; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Rifampin; Streptococcus pneumoniae; Time Factors; Vancomycin

2002
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Disease Models, Animal; Fluoroquinolones; Foreign-Body Reaction; Guinea Pigs; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2002
Release of netilmicin and vancomycin from cancellous bone.
    Acta orthopaedica Scandinavica, 2002, Volume: 73, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bony Callus; Disease Models, Animal; Femur; Gentamicins; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Netilmicin; Rabbits; Time Factors; Vancomycin

2002
Silkworm larvae as an animal model of bacterial infection pathogenic to humans.
    Microbial pathogenesis, 2002, Volume: 32, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bombyx; Disease Models, Animal; Drug Therapy, Combination; Humans; Inhibitory Concentration 50; Larva; Lethal Dose 50; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin; Vibrio cholerae

2002
The nephrotoxicity of antimicrobial agents (second of three parts).
    The New England journal of medicine, 1977, Mar-31, Volume: 296, Issue:13

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Glomerular Filtration Rate; Guinea Pigs; Half-Life; Humans; Kidney; Kidney Diseases; Polymyxins; Rabbits; Rats; Tetracyclines; Vancomycin

1977
Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea.
    Gut, 1979, Volume: 20, Issue:6

    Topics: Animals; Cecum; Clindamycin; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Intestinal Mucosa; Mesocricetus; Microscopy, Electron; Vancomycin

1979
Induction and prevention of experimental arteriovenous fistula infections.
    Antimicrobial agents and chemotherapy, 1979, Volume: 16, Issue:5

    Topics: Animals; Arteriovenous Fistula; Disease Models, Animal; Oxacillin; Rabbits; Staphylococcal Infections; Vancomycin

1979
Clindamycin-induced colitis.
    The American journal of clinical nutrition, 1979, Volume: 32, Issue:1

    Topics: Animals; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Mesocricetus; Metronidazole; Vancomycin

1979
Clindamycin-associated colitis in hamsters: protection with vancomycin.
    Gastroenterology, 1977, Volume: 73, Issue:4 Pt 1

    Topics: Animals; Clindamycin; Colon; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gentamicins; Lincomycin; Male; Vancomycin

1977
The protective effect of vancomycin on clindamycin-induced colitis in hamsters.
    The Johns Hopkins medical journal, 1977, Volume: 141, Issue:4

    Topics: Administration, Oral; Animals; Clindamycin; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Injections, Subcutaneous; Intestines; Male; Vancomycin

1977
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
    The Journal of infectious diseases, 1975, Volume: 131, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cephalothin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Penicillins; Rabbits; Rifampin; Staphylococcal Infections; Time Factors; Vancomycin

1975
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
    The Journal of clinical investigation, 1975, Volume: 56, Issue:2

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin

1975
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:1

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Peptides; Rats; Teicoplanin; Vancomycin

1992
[Comparative study of the therapeutic effect of the glycopeptide antibiotics eremomycin, vancomycin and ristomycin in a model of antibiotic-associated colitis in golden hamsters].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:11

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Colitis; Cricetinae; Disease Models, Animal; Female; Glycopeptides; Injections, Intraperitoneal; Lincomycin; Mesocricetus; Ristocetin; Vancomycin

1992
Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.
    European journal of epidemiology, 1992, Volume: 8, Issue:3

    Topics: Animals; Candida albicans; Candidiasis; Cytarabine; Disease Models, Animal; Female; Gastrointestinal Diseases; Gentamicins; Immunocompromised Host; Intestinal Mucosa; Methylprednisolone; Rabbits; Vancomycin

1992
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
    Investigative ophthalmology & visual science, 1992, Volume: 33, Issue:11

    Topics: Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1992
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
    Current eye research, 1992, Volume: 11, Issue:11

    Topics: Animals; Cefazolin; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Methicillin Resistance; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1992
Experimental postoperative endophthalmitis.
    Transactions of the American Ophthalmological Society, 1992, Volume: 90

    Topics: Animals; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Microbial Sensitivity Tests; Postoperative Complications; Rabbits; Vancomycin

1992
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
    The Journal of infectious diseases, 1991, Volume: 163, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Microbial; Fleroxacin; Foreign Bodies; Gentamicins; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1991
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
    The Journal of laboratory and clinical medicine, 1990, Volume: 116, Issue:5

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin

1990
Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence.
    The Journal of hospital infection, 1990, Volume: 15, Issue:2

    Topics: Animals; Disease Models, Animal; Humans; Male; Methicillin; Mice; Mice, Inbred ICR; Penicillin Resistance; Prospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virulence

1990
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Fleroxacin; Foreign-Body Reaction; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1990
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:6

    Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin; Osteomyelitis; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin

1990
Lack of extracellular slime effect on treatment outcome of Staphylococcus epidermidis experimental endocarditis.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:1

    Topics: Animals; Disease Models, Animal; Endocarditis, Bacterial; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

1989
Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Cricetinae; Daptomycin; Disease Models, Animal; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin

1987
LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:1

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Male; Microbial Sensitivity Tests; Peptides; Pyelonephritis; Random Allocation; Rats; Rats, Inbred Strains; Streptococcal Infections; Vancomycin

1988
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1

    Topics: Animals; Bacterial Proteins; Bacterial Toxins; Clostridium; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Latex Fixation Tests; Recurrence; Saccharomyces; Vancomycin

1987
Pharmacokinetics of intraventricular vancomycin in hydrocephalic rats.
    Neurosurgery, 1986, Volume: 18, Issue:6

    Topics: Animals; Disease Models, Animal; Hydrocephalus; Injections, Intraventricular; Kinetics; Male; Rats; Rats, Inbred Strains; Vancomycin

1986
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    The Journal of infectious diseases, 1985, Volume: 151, Issue:1

    Topics: Animals; Creatinine; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Kidney; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1985
[Studies on the hamster colitis model].
    Wei sheng wu xue bao = Acta microbiologica Sinica, 1985, Volume: 25, Issue:1

    Topics: Animals; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Female; Gentamicins; Male; Mesocricetus; Penicillin G; Vancomycin

1985
Therapy of experimental staphylococcal infection with antibiotic combinations.
    The Journal of laboratory and clinical medicine, 1974, Volume: 83, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Disease Models, Animal; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Gentamicins; Lincomycin; Mice; Oxacillin; Staphylococcal Infections; Vancomycin

1974